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The cytotoxic actions of pineal indoles were studied on different tumor cell lines 
inchiding mouse melanoma cell line (BI6), human choriocarcinoma cell line (JAr), 
sarcoma cell line (S 180), macrophage-like cell line (PU5) and fibroblast cell line 
(3T3). The pineal indoles examined included melatonin, methoxytryptamine, 
methoxytryptophol, hydroxytryptophol, serotonin, hydroxyindoleacetic acid and 
methoxyindoleacetic acid. It was found that methoxytryptamine inhibited 
incorporation of 3H-thymidine, 3H-uridine, and--~H:-Ieucine into mouse melanoma cells 
with t4e highest p~tency. 3H_ Thymidine incorporation into--sarcoma and 'PU5 cells 
~ 
was inhibited by methoxytryptamine with the highest potency. Methoxytryptamine 
exerted the most -potent inhibitory effect on crystal violet uptake by fibroblasts. 
Serotonin and hydroxyindoleacetic acid exhibited low inhibitory potencies in the 
-aforementioned cell lines. Neither melatonin nor methoxytryptamine increased the 
-release of glutamate-oxaloacetate transaminase by cultured rat hepatocytes into the 
culture medium although there was a slight enhanc~ment of release of glutamate 
pyruvate transaminase and . a slight inhibition of crystal violet uptake by the 
hepatocytes. The results indicate that various pineal indoles exerted cytotoxic actions . 
. ". ~f;. _ 
against tumor cell lines but had little or no effect on the . viability of hepatocytes. 
Both in. vivo and in vitro treatments with melatonin and methoxytryptamine produce~ 
an increase in nitrite production by peritoneal macrophages, suggesting that the pineal 
indoles exert both direct cytotoxic· actions on tumor cells as well as indirect antitumor 
effects by- enhancing the tumoricidal activity of macrophages. Treatment with 
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methoxytryptamine under In VIVO and in vitro conditions caused peritoneal 
macrophages to generate less hydrogen peroxide, but similar treatment with melatonin 
did not produce a marked alteration in hydrogen peroxide production. Both in vivo 
and in vitro treatment with melatonin led to an increased superoxide production by 
peritoneal macrophages. On the other hand, in vitro methoxytryptamine treatment 
produced an increase in superoxide but in vivo methoxytryptamine · treatment 
produced just the opposite. The results suggest that superoxide and hydrogen peroxide 
contribute little to the enhancement. of tumoricidal activity of peritoneal mactophages 
by pineal indoles. In vivo treatm~nt with melatonin and methoxytryptamine led to 
an increase in production. of tumor necrosis factor-a and jts mRNA-by ~ritonea1 
macrophages, while ,in vitro methoxytryptamine decreased and in vitro melatonin 
/treatment did not have any effect on production of tumor -necrosis factor-a. The . 
results suggest that the secretion of hydrogen peroxide and the secretion of nitrite 
involve two independent pathways and that there are some ~ferences between the 
immunomodulatory actions of melatonin and methoxytryptamine. Some of the · 
. .-- - - -- - -- - _.-
discrepancies between the actions of pineal indoles in vivo and in vitro may be 
attributed to-the fact that- in thein 'vivo study the .macrophages .had been primed or 
stimulated ' by the pineal indole for a longer duration and they · subsequently 
demonstrated a great~r response to; the sti~ulant in vitro. !he ability of melatonin 
and. methoxytryptamine to augment production 'of nitrite, and tumor necrosis factor, 
which are molecules involved in the ' combat against tumor cells, is consistent with 
the in vitro cytotoxic actions of the pineal indoles. 
. . 
. When compared to splenocytes from control mice, splenocytes from melatonin-treated 
2 
mice exhibited greater mitogenic responses to concanavalin A and lipopolysaccharide 
while splenocytes from methoxytryptamine-treated mice manifested· a lower mitogenic 
response to concanavalin A and a greater mitogenic response to lipopolysaccharide. 
Splenocytes from both melatonin-treated and methoxytryptamine-treated mice , 
produced more 'Y-interf~ron and interleukin-2 than splenocytes from control mice, 
with melatonin exerting a stronger stimulatory effect. Crude lymphokines from 
splenocytes of melatonin -treated and methoxytryptamine-treated , mice were able to 
• 
stimulate nitrite production by peritoneal macrophages (from control mice, melatonin-
treated mice, as well as from methoxytryptamine-treated mice) to a greater extent 
. than crude lymphokines from ' splenocytes of control mice, suggesting that ' 
macrophage activating factor was present at higher concentrations in preparations of 
/ crude lymphokines from splenocytes of melatonin-treated and methoxytryptamine-
treated mice than crude lymphokine preparation from control mice., Crude 
lymphokines from melatonin-treated mice had a greater , stimulatory effect on 
macrophage nitrite production, implying that melatonin exerted a greater stimulatory 
effect on lymphocytes than methoxytryptamine. Macrophages from melatonin-treated 
and methoxytryptamine-treated mice produced more, nitrite , than. ·macrophages from 
control mice when they were activated by crude lymphokines from melatonin-treated 
mice or methoxytryptamine-treated mice, suggesting that macrophages , from' 
mel.atonin-treated and methoxytryptamine-treated mice were more sensitive to the 
action of lymphokines than macrophages from control mice. Macrophages from 
methoxytryptamine-treated mice produced the highest nitrite level indicating that 
methoxytryptamine treatment exerted a stronger stimulatory effect on macrophages 
. than melatonin. Crude lymphokines from melatoI?-in-treated mice but not those from 
3 
- - ' 
methoxytryptamine-treated mice were able to stimulate greater inhibition of the 
growth of murine mastocytoma P8I5 cells by macrophages from control mice, 
melatonin-treated mice and methoxytryptamine-treated mice when compared to crude 
lymphokines from control mice, indicating that macrophage activating factor was _ 
. present at a higher con~entration by crude lymphokines from melatonin-treated mice 
and that melatonin exerts a stro'nger stimul~tory effect <?n lymphocytes than 
methoxytryptamine. Macrophages from both melatonin-treated and 
methoxytryptamine-treated mice elicited greater inhibition of the growth of PSI5 cells 
than macrophages from contro~ mice when they were stimulated by crude' 
lymphokines from melatonin-treated mice, suggesting ' that macrophages from 
melatonin-treated and methoxytryptamine-treated mice were more sensitive than 
/macrophages from control mice to -crude lymphokine preparation from melatonin-
treated mice. Again the higher response observed in-· macrophages from 
methoxytryptamine-treated mice suggest that methoxytryptamine exerts a stronger 
stimulatory effect on macrophages than melatonin. The lack of differential response 
. among macrophages of the vari~us groups of ;cice'to c~de lymphokines from control 
-,mice-'and methoxytryptamine-treated mice may be attributed to the-lower activity of 
macrophages activating factor in these lymphokine preparations. 
I 
Results of this study revealed a cytoto~c action of pineal indoles on tumor celr lines 
. and an immunostimulatory action onmacrophages and splenocytes. 
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Chapter 1 General Introduction· 
1.1 The pineal gland 
The human pineal gland, also called epiphysis cerebri, is located near the third 
ventricle of the brain. It measures ' about 5 - 8 mm in length and 5 mm in width, 
weighs about 2 g and is coated with a soft membrane. Blood from the heart enters 
the pineal gland via the posterior cerebral arteries and leaves it via the great' cerebral 
veins (Williams & Warwick 1980). 
1.2 Discovery of melatonin . 
Melatonin and its derivatives were studied in this project Melatonin was fIrst 
isolated in 1958 by Lemer et al. They found that melatonin inhibited pigment cells 
and suggested that melatonin would inhibit melanoma (Lerner 1958). 
1.3 Synthesis of melatonin 
In the pinealocytes, tryptophan is hydroxylated by tryptophan hydroxylase to form 
5-hydroxytryptophan (Lovenberg 1967). 5-Hydroxytryptophan is then decarboxylated 
by L-aromatic amino acid decarboxylase to form 5-hydroxytryptamine, i.e. serotonin 
(Lovenberg 1962). Serotonin in the pineal gland has several metabolic fates. First, 
it may be converted into melatonin by the action of 2 enzymes, N-acetyltransferase 
and hydroxyindole-O-methyltransferase. Second, it may undergo O-methylation to 
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form 5-methoxytryptamine by hydroxyindole-O-methyltransferase (Axelrod 1961). 
Third, it may undergo oxidative deamination to fonn 5-hydroxyindole acetaldehyde 
with the help of monoamine oxidase (Keglevic 1968). 5-Hydroxyindole acetaldehyde 
can then be oxidized to form 5-hydroxyindole acetic acid and 5-hydroxytryptophol. 
5-Hydroxyindoleacetic acid and 5-hydroxytryptophol may undergo O-methylation to 
form 5-methoxyindoleacetic acid and 5-metho~ytryptophol respectively by 
hymoxyindole-O-methyltransferase (Miles 1988). Because of their pineal origin 'and 
possession of an indole nucleus in their molecules, melatonin and its derivatives are 
named pineal indoles. 
1.4 Physiology of melatonin and its derivatives 
The pineal gland is known as a neurochemical transducer (Axelrod 1974). It seems 
to translate photoperiodic infonnation into chemical message. Melatonin is believed 
to be the chemical messenger because of its circadian changes in serum level 
. - - '. - ' 
(Josephine 1988). Its blood concentration peaks at night and is maintained low in the 
daytime (Reiter 1991). Nocturnal serum melatonin concentration in __ healthy young 
" " 
men was about 100 pg/ml while that in old men was about 20 pg/ml. 
Different hamster and rat organs have been sho'wn to have cytoplasmic melatonin 
receptors. The presence of melatonin , receptor was demonstrated by using the 
agoni~t, 2-:-[1251] iodomelatonin and the competitive antagonist, luzindole (Margarita 
1988). The ovary,. uterus, liver, ey~, "thyroid, and testis showed different " melatonin 
"binding with KD values around 250 fmol per mg protein (Michael 1978). The 
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function of the pineal as a transducer is especially important to photoperiod-sensitive 
mammals which are mostly seasonal breeders. In these mammals the reproductive 
potential of the gonad fluctuates with circadian changes in photoperiod and thus with 
the melatonin level (Reiter 1980). Pineal indole's have been shown to inhibit , 
steroidogenesis in isolated rat Leydig cells as a result of inhibition mostly on 17-20 
desmolase (Ng 1987, Ng 1988, 001 1989). The number of graafian follicles and 
corpora lutea and the thickness of uterine myometrium and endometrium were also 
reduced in female hamsters treated with pineal indoles (Ooi 1989). Both evidences 
show an inhibitory effect of pineal indoles on the reproductive system. Lennart 
(1976) tested the melatonin concentration in serum samples collected ' earry in the 
morning during the menstnial cycle of 5 healthy women and found that the highest 
melatonin level occurred at the time of me'nstrual bleeding and that the lowest 
concentration accompanied the peak of luteinizing hormone. He suggested that low 
melatonin concentration at the mid~cycle was a permissive factor for ovulation. Chik 
(1985) also found that morning luteinizing hormone' level was elevated in 
pinealectomized patients. Besides, melatonin may regulate several neuroendocrine 
functions such-as, sleep-and pituitary hormone secretion in humans (Margarita 1988). 
1.5 In vitro tumor biology of melatonin and its, derivatives 
Blask & Hill have written an extensive review on the antitumor aspects of melatonin 
(Blask 1988). Blask suggested that the pineal is an oncostatic gland with melatonin 
playing a major oncostatic role. The effect of melatonin on cell growth, especially 
that of tumor cells, has been widely studied in the last decade. Some of the results 
\ 7 
suggest the role of melatonin as an '" oncostatic convoy. Melatonin seems to be more 
effective on hormone-responsive tumors. 
Banerjee (1972) reported that melatonin inhibited cell division in protozoans. 
Margulis (1973) found ~hat melatonin inhibited cell division in onion root tips. In 
the prepubertal rat, pinealectomy prevented the inhibitory effect of light deprivation 
on the proliferation of anterior pituitary cells (Blask 1984). 
Boucek .& Alvarez (1970) studied the effect of serotonin & N-acetylserotonin, the 
. . " 
"precursors of melatonin, on 5 different cell lines. Serotonin was fou'nd to stimulate 
3T6 & human embryonic 'lung fibroblasts while N-acetylserotonin was found to 
inhibit cell proliferation by 30 %. Neither of them at 10-7 M--had" any effect on Hela 
cells (hum'an cervical carcinoma), KB cells (human oral epidermoid carcinoma) or 
BHK cells (golden hamster kidney). Hill (1986) reported that melatonin, N-
acetylserotonin and serotonin did not inhibit proliferation of mouse 3T3 and 3T6 and 
human foreskin fibroblast cell lines (Hill 1986). 
Walker (1978} detected a biphasic effect of melatonin on.the cloned melanoma cell 
line" B7 obtained from " spontaneously arising tumors in a male golden hamster. 
Mel.atonin at millimolar concentrations showed 25 % inhibition of 3H-thymidine 
uptake but melatonin at micromolar concentrations showed 37 % stimulation. There 
are discrepancies when these results are compared to ~hose of Bartsch. Bartsch 
(1984) observed that melatonin elicited 60 % inhibition at micromolar concentrations 
but produced a moderate stimulation of 3H-thymidine uptake by human melanoma 
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cells at a 10 - fold higher concentration. 
Much work has been done using the human breast cancer cell line MCF-7 which 
possess both estrogen & prolactin receptors. Melatonin at a concentration of 10-11 M 
- 10-9 M, which is wit4in the physiological range in human blood, caused 75 % 
inhibition of cell proliferation in culture, while other indoles such as serotonin, N-
acetylserotonin, 5-methoxytryptophol, 5-methoxytryptamine in the same dose range 
did not have any effects on proliferation of MCF-7 cells (Hill 1986). Osborne (1985) 
tested melatonin and tamoxifen, a non-steroidal antiestrogen, on MCF-7 cells. He 
found that ' nanomolar concentrations of melatonin were more effectiVe than 
micromolar concentrations of tamoxifen in inhibiting the growth of M CE-7 cells. 
However, combined treatment with melatonin and tamoxifen produced a degree of 
growth suppression similar to that of tamoxifen alone. Since tamoxifen was found 
to block the antiproliferative effects of melatonin and known to bind to estro gen 
receptors, he postulated that melatonin exerted antiproliferative effects on MCF-7 
cells through an interaction with estradiol receptors. Vignon and Rochefort (1985) 
observed that melatonin inhibited the release of the estradiol-inducible 52 K 
glycoprotein which stimulated the growth of MCF-7 cells in an autocrine fashion. 
Blask and Hill (1986) found that melatonin at 10-9 M did not have any inhibitory 
effect but melatonin ~at 10-6 M caused 40 % inhibition of the growth of the estrogen 
receptor-positive human endometrial cancer cell line RL95. They also found that 
melatonin , was completely ineffective as a growth inhibitor of the human breast 
cancer cell line BT20 ,which was ,devoid of estrogen receptors and hence estrogen -
unresponsIve. Danforth (1983) found that melatonin increased the estrogen receptor 
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binding activity of M CF-7 cells. He projected melatonin as a fac,tor to be considered 
for use in treatment since patients with hormone-dependent (ER-positive) breast 
cancer have a significantly higher response to honnonal manipulation and a better 
prognOSIS. 
When tested on the human ovarian carcinoma cell lines SK-OV-3 and JA-1 and the 
bladder carcinoma cell line RTl12, melatonin and N-acetylserotonin exerted a 
significant growth inhibitory effect in vitro only at relatively high concentrations (0.5 
- 1 mg/ml) while 5-methoxytryptamine and 6-hydroxymelatonin were 5 .times .more 
effective (Shellard 1989). .,~ .-
1.6 In vivo tumor biology of melatonin 
Different animals bearing different tumors were either pinealectomized or melatonin-
treated to study the effects of melatonin on the tumors and the survival of the 
animals. Secretion·· of mehitonin in the animal was prevented by pinealectomy or 
subjection to a long photoperiod. Lapin (1976)- and Blask-(1984) observed that 
pinealectomy in mice bearing Erhlich's tumors enhanced tumor growth. Bartsch 
(198'1) found that melatonin inje~tions in the late-afternoon suppressed the growth of , 
Erhlich's tum.or significantly in mice subjected to a long photoperiod. Lapin (1981) 
found that pinealectomy in rats bearing Yoshida tumors stimulated tumor growth 
while melatonin administration prevented the stimulation of tumor growth and thus 
enhanced the survival time of the rats. It is another evidence of melatonin being an 
oncostatic convoy of the animal. 
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Barone (1972) observed that pinealectomy in rats markedly enhanced the growth of 
fibrosarcomas. Bartsch (1981) found that melatonin administration·in mice subjected 
to a photoperiod of 13L: lID during the late afternoon inhibited the growth of 
fibrosarcomas. The growth of various carcinomas in different animals was enhanced 
after pinealectomy. Th~y included ovarian carcinomas (Das Gupta 1968), Walker 
256 (Rodin 1963), hormone-responsive hamster melanotic melanomas (Stanberry 
1983), and mammary tumors (Blask 1984). Different carcinomas in different animals 
were found to be regressed after melatonin administration in the late afternoon. They 
included androgen-sensitive rat prostatic carcinomas, Lewis lung carcinomas (Lapin 
1976), honnone-responsive hamster melanotic melanomas (Stahberry 1983j;--mouse 
melanoma cells (Narita & Kudo 1985), DMBA-induced mammary tumbrs (Blask 
1986) and breast tumors (Karmali 1978). The growth of carcinomas in rats subjected 
to a short photoperiod was also suppressed. They included diethylstilboestrol-induced 
pituitary prolactinomas (Leadem 1987) ,and mammary tumors (Chang 1985). 
Mice in some laboratories spontaneously developed mammary tumors which were 
"known to have a -viral-etiology. Those-mice which receivecLmelatonin in the drinking 
water were found to have a lower incidence of the mammary tumors than control 
mice which received ,alcohol in the drinking water. Subramanion (1991) suggested 
• c 
that ,melatonin was a ' suppressor of spontaneous murine mammary tumors. 
1.7 Macrophages 
Macrophages are mononuclear phagocytes which are able to ingest "non-self" 
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antigen-associated cells or substances and digest them in the lysosomal compartments. 
About 5· - 10 % macrophages carry class 11 major histocompatibility complex 
·molecules and these macrophages are also antigen-presenting cells. They process 
antigens, associate the antigens with major histocompatibility complex molecules, and 
present the modified anti~ens to T lymphocytes and B lymphocytes. Macrophages 
produce and secrete IL-l which is essential for T cell activation. 0,-Interferon, which 
is known as leukocyte interferon, is produced by macrophages. The secretory 
functions of macrophages are important for them to serve as effector cells. ,Neutral 
proteases including plasminogen activator, collagenase and elastase, and several 
potent oxidizing ag~nts such as superoxide, nitrite and hydrogen peroxide are§J~creted 
by activated macrophages . . Tumor necrosis factor - a, is also secreted by activated 
macrophages (Old 1985). Macrophage activation is known to be divided into priming. 
and activating stages. A low concentration of "I-interferon is required to initiate the 
priming-- stage. A high concentration of "I-interferon or lipopolysaccharide is then 
necessary for the primed macrophages to enter the activating stage. 
Generally, macrophages are in either a free or a fixed state. Histiocytes, alveolar 
macrophages, peritoneal macrophages, and pleural macrophages are typicru. types of 
free .macrophages. Fixed tissue macrophages of the spleen and lymph nodes, Kupffer 
cells of the liver, microglial cells of the nervoussystem~ osteoclasts of the bone, and 
synovial type A cells of the joint are alllypical types of fixed macrophages. All of 
the hematopoietic cells such as erythrocytes, granulocytes and mononuclear 
phagocytes are derived from the common pluripotent stem cells. Onl~ after the 
appearance of the monoblasts, the first proge~itor cells of macrophages; the 
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granulocytic senes and the monocytic senes are separated from the common 
'committed stem cells. Monoblasts are round cells with few basophilic granules, Fc 
receptors and esterase reactivity. These monoblasts differentiate into promonocytes 
which ' stain azurophilic and possess myeloperoxidase-positive granules. The 
promonocytes mature into monocytes which have fewer myeloperoxidase-positive 
granules and a lower nucleus to cytoplasm ratio. These monocytes are released into 
the blood .and circulate throughout the body. When the monocytes leave the 
circulating pool and emigrate into 'the extravascular environment, they ' Iurther 
differentiate into mature macrophages under the influence of suitable mitogens such 
as macrophage specific colony stimulating factor. 
Migration of macrophages may be in a random manner or specifically direct toward 
a chemical stimulus, i.e. chemotaxis. When macrophages are attracted toward a 
specific location, they must be prevented from random migration by some factors. 
Substances responsible for retention of macrophages are known to be lymphokines 
such as macrophage migration inhibitory factor and macrophage activation factor, 
proteolytic enzymes such as--factor Bb of the complement activation ' system, and 
plasmin of the fibrinolytic system. Substances which directed the movement of 
macrophages are named chem,otactic agents. C5a, which is an anaphylatoxin 
produced-in--the -activation ' of complement by antigen-antibody c6mplexe's in both 
classical and alternative pathways, is also a typical chemotactic agent. Bacterial 
products like N-formylmethionyl peptides and some products from stimulated T and 
B lymphocytes also show chemotactic activities. 
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Several lines of evidences suggest the involvement of macrophages in the growth of 
tumors. Macrophages often infiltrate into tumors. Macrophages explanted from 
regressing tumors are more cytotoxic than macrophages explanted from progressing 
tumors~ The size of the macrophage population infiltrating into the tumors seems to 
correlate with the metastatic ability of , the tumor. Immunotherapy against tumors 
always elicits infiltration of mononuclear phagocytes. Injection of bacille Calmette-
Guerin or Corynebacterium Parvum for immunostimulation enhances the ability of 
the recipient's macrophages to kill tumors in vitro (Nathan 1980). Melatonin has 
shown its antitumor potential. both in vitro and in vivo. The effects of melatonin on 
macrophages were hence studied in this project. 
1.8 Lymphocytes 
Lymphocytes are divided'into T lymphocytes .and B lymphocytes. T lymphocytes are 
derived from the thymus. When T cells mature, they migrate from the cortex to the 
medulla of the thymus. Matured T cells move into efferent lymphatics, large 
lymphatic ducts, then into the thoracic ducts, and finally into the. bloodstream . . They 
are localized in different organs such as lymph nodes, spleen, Peyer's patches, etc. 
When the stem cells move into the thymus, they begin to express the CD2 molecules, 
. ' 
which are receptors by which T cells (form rosettes with the sheep red blood cells. 
Then they further differentiate into CD2+CD3+CD4+ T cells or CD2+CD3+CD8+ T 
cells. CD4+ T cells comprise 65 % peripheral T cells while CD8+ T cells comprise 
35 % peripheral T cells. The C~4 molecules on T cells interact with antigens 
associated with class 11 major histocompatibility complex molecules. The CD8 
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molecules on T cells interact 'with antigens associated with class I major 
histocompatibility complex molecules. The activation of T cells requires several 
signals (Roitt 1989). First, IL-l secreted by the activated macrophages, antigens 
associated with suitable major histocompatibility complex molecules, or -mitogens 
activate 2 signals in the T cells. Second, an increase in inositol trIphosphate elevates 
the cytoplasmic level of free calcium by mobilizing . calcium from. the intracellular 
stores in the endoplasmic reticulum. Third, an increase in diacylglycerol activates 
protein kinase C. These signals act in concert to initiate growth and prolifera.tion of 
T cells. Further developments of T cells require IL-2, which is secreted by activated 
T cells and known ·as T cell growth factor, and the number of IL-2receptofs·-on the 
activated T cells increased. IL-2 is also necessary for the development of cytotoxic 
effector CD8+ T cells. Activated T cells secrete migration inhibiting factor which 
inhibits the random migration of activated macrophages and makes them accumulate 
around the area ··of activation. Activated T cells also secrete y-interferon which 
enhances the cytolytic activity of the accumulated macrophages. 
B ._ cells are derived from stem -cells-which--are fIrst located in the ·fetal liver and 
subsequently migrate to the bone marrow. The stem cells differentiate into pre-B 
cells. They lack immunoglobu~s at frrst and are able to synthesize the heavy chains 
of immunoglobulins later. These lymphoblasts are unable to produce the light chains . 
of immunoglobulins. The pre-B cells enter into the resting stage of B cells when 
they express surface immunoglobulins. Several surface markers are carried by the 
different stages of B cells. Th~ resting B cells are 8+/Ba-, IL-4 R+, IL-6 R- (R 
denotes the receptor, + indicates presence, - in~cates absence). The previous process 
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does not require an antigen. Activ'ation of resting B cells into activated and mature 
stages requires T -dependent antigens or T -independent antigens. 'The B cells ingest 
the antigens either specifically or nonspecifically, internalize them and express the 
antigens with class 11 major histocompatibility complex molecules which are then 
recognized by the T cell antigen receptor on TH cells. IL-4 which is secreted by TH 
_ cells and known as B cell growth factor and the IL-l secreted by the macrophages 
stimulate the resting B cells to enlarge and enter the cell cycle. The activated B cells 
then change into 8-/Ba+, IL-4 R++; and IL-6 R+. IL-2, IL-4, IL-5 and T -interferon are 
, required for the proliferation . of the activated B cells. ,IL-6, which is the most 
. ' 
important differentiation factor of B cells, IL-2, IL-4, IL-5, and T -interferon ate then 
required for the differentiation of B cells. The mature B cells finally change into 
8-lBa++, IL-4 R+, and IL-6 R+++. There is a down-regulation of IL-4 receptors and an 
up-regulation of IL-6 receptors. The B cells may change into active antibody-
producing plasma cells. They may change into memory cells to wait for the initiation 
of secondary immune response by the same antigen. The memory cells are 8-/Ba-. 
In addition to the help of the lymphokines from T cells, B cells can be activated by 
T -independent 'antigens through either~receptor cross-linking or-mitogenic action~ The 
receptor cross-linking leads to activation of phospholipase C and generation of 2 
second messengers within seconds. It results in an increase of cytoplasmic Ca ++ and 
activation of protein -kinase C. Mito gens are believed to lead to an increase in the 
level of calcium ions. They also act in concert to lead to an activation of B 
lymphocytes. 
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Chapter 2 Toxicity of pineal indoles on tumor cell lines 
2.1 Introduction 
The relationship between.melatonin and cancer has been reviewed by Blask and Hill 
(1988). The general consensus is that the pineal is an oncostatic gland (Kerenyi et 
al., 1990) although t~ere was some evidence to the contrary. 
Melatonin inhibited estradiol-in~uced 3H-thymidine incorporation into the DNA of 
MeF - 7 human breast cancer cells (Blask and ·Hill, 1986a). It also suppre~ed the 
. growth of fibrosarcomas (Bartsch and Bartsch, 1981), prostatic carcinomas (Philo and 
Berkowitz, 1988; Toma et al., 1988), melanomas (Narita and Kudo,- -1985), 7,12-
-dimethylbenzanthracene-induced mammary tumors (Blask et al., 1986) and 
spontaneous mammary tumors (Subramanian and Kothari, 1991). Bartsch and 
Bartsch (1981) observed in mice that melatonin-administration suppressed the growth 
-.- -- --- _. - -
of Erlich' s solid tumors. Lapin and Frowein (1981) noted in rats that pinealectomy 
promoted the growth of Y oshida solid tumors and that melatonin reversed the effect 
of pinealectomy and prolonged survival time. Pinealectomy enhanced growth of . 
ovarian carcinomas (Das Gupta, 1968) and Walker 256 carcinomas (Barone and Das ,~ ~.-
Gupta, 1970) and accelerated metastasis of the latter- (Barone and·Das Gupta, 1970). 
However, in human cancer patients no consistent changes in the secretory pattern of 
melatonin compared with healthy individuals· could be detected (Blask and Hill, 
1988). 
17 
In addition to melatonin, other pineal products have been found to possess antitumor 
, activity. A low molecular weight and protease-resistant compound, di'stinct from 
melatonin, serotonin, pteridines and B-carboline, with an inhibitory effect on the 
growth 'of human melanoma cells in vitro, was purified from an aqueous extract of 
ovine pineals (Notebom ' et al., 1988). Shellard et al. (1989) showed that 
_ methoxytryptamine was more potent than melatonin in inhibiting growth of several 
tumor cell lines including SK-OV-3, JA-1 (ovarian carcinoma cells), RTI12 (bladder 
tumor cells) and MCF-7 (breast tumor cells). 
The intent of the present investigation was to examine the effect of melatonin 
together with other pineal ' indoles on a variety of tumor cell lines including 
fibroblasts (3T3), 'macrophage-like cell line (PU5), -mouse melanoma (B 16) and 
choriocarcinoma (JAr). 
2.2 Material and methods 
2.2.1 Cell lines 
The mouse .melanoma cell line (B16) was obtained from Dr. K~ Yamada, Department 
of Dermatology, University of Tokyo. The human choriocarcinoma cell line (JAr) 
was obtained from Dr. R.A. Patillo, Medical College of Wisconsin. The sarcoma cell 
line (SI80), macrophage-like cell line (PU5) and fibroblast cell line (3T3) were 
obtained from American Type Culture Collection. The PU5 and 3T3 cell lines were 
routinely maintained as monolayersjn.RPMI 1640 (Sigma, catalog no. R 6504). The 
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B 16 cell line was routinely maintained as monolayers in Nutd.ent Mixture F-10 Ham 
(Sigma, catalog no. R 6635). The S 180 and JAr cells were maintained as suspension 
cells in RPMI 1640. All culture media were supplemented with 10% fetal calf 
serum and streptomycin sulphate (100 Jlg/ml) and penicillin G (100 IU/ml). 
\, 
Dulbecco's phosphate buffered saline (Sigma, catalog no. D 5652) was used for 
washing. Generally, they were fIrst unpacked and dissolved in 800 ml fresh double-
distilled water. They were stirred gently for 3 - 4 hours. 2 g sodium bicarbonate 
was then added to RPMI, 1.2 g sodium bicarbonate was added to F10 and' 0.1 g 
MgCl2-6 H20 and 0.133 g CaC12-2 H20 were added to Dulbecco's phosphate-
buffered saline. The ' solution was stirred for a few minutes. The pH of the ~plution 
was adjusted to 7.2 while stirring. Then the volume of the solution was adjusted to 
1/ L with fresh double-distilled water. Finally, the medium was sterilized by filtration 
using sterile 0.22 Jlm millipore filter. The sterile-medium was then transferred to a 
sterile container for storage. 
2.2.2 Incorporation of radioactive precursors 
Radioactive precursors (methyl-3H-thymidine, L-4,5-3H-I,eucine, 5-3H-uridine) were 
purchased from Amersham. Cells in the exponential growth phase were _ used. Cells 
(104) in triplicate were seeded-intoeaqh-well of 96-well plates and incubated for 48 
hours with different concentrations of serotonin, melatonin, hydroxyindoleacetic acid, 
methoxytryptophol, methoxytryptamine, methoxyindoleacetic acid and 
hydroxytryptophol (Sigma Chemical Co.). Radioactivity (0.5 JlCi/10 JlI) was added 
. to each culture well at the end of experiment and incubation continued for another 
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6 hours. The cultures were then harvested by a cell harvester. The incorporated 
radioactivity was detennined by liquid scintillation counting. 
2.2.3 Preparation of scintillation fluid 
0.4 g POPOP and 4 g PPO were dissolved in 700 ml toluene and the mixture was " 
stirred for 3 hours. 300 ml Triton X-I 00 was then added into the mixture to bring 
the volume to 1 L. " 
2.2.4 Determination of cell viability by uptake of crystal violet 
/ " 
After incubation with pineal indoles for 48 hours the cells were subjected to staining 
with crystal violet (0.5 % in methanoVwater : 1/4 by volume) for 3 minutes. 
Afterwards they· were washed with phosphate buffered saline twice and then dried. 
They were lysed by lysis buffer which contains 1 % acetic acid - 50 % alcohol. The 
quantity of crystal violet taken up by the cells was determined using a micro ELISA 
autoreader (3550 Bio-Rad microplate reader) at 595 nm. 
2.2.5 Hepatocyte experiment 
Rat hepatocytes were isolated from male Lewis rats according-" to the method 
described by Kreamer et al. (1986). " Rats weighing 250 g were anesthetized with 
sodium pentabarbital" and the livers were-fIrst perfused with warm Ca++-free Hank's 
balanced salt solution (HBSS) fortified with 15 mM HEPES to remove blood cells 
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before the liver tissues were perfused with 100 ml HBSS containing 50 mg 
collagenase (Type IV from Clostridium Histolyticum, Catalog no. C5138, Sigma, 
USA) for 10 minutes. The perfusion rate and temperature were maintained at 20 
ml/min : and 35°C. The digested liver · was then removed and dissociated 
mechanically in 50 ml of . collagenase - supplemented perfusate. Liver cells were 
obtained by filtering the solution through a sterile nylon mesh (250 ~m pore size, 
Baltex 25-T, Polyester Monofilament, Switzerland) and then centrifuging at 50 g for 
3 min. The cells were rinsed twice in Medium M199 supplemented with glucose (1.5 
g/l), streptomycin (100 mg/l), penicillin (100 IU/ml), insulin (0.5 mg/l), transferrin 
. . 
(5 ~g/ml), sodium ·selenite (5 ng/ml) and 10% fetal calf serum, count~ and 
resuspended to a concentration of 5 to 10 X 106 cells/ml fresh medium. Twenty-five 
milliliters of liver cell suspension was mixed with 24 ml of sterile isosmotic percoll 
solution to produce a final density of 1.06 g/ml. -Cells with about 90 to 95 % 
viability were obtained by centrifuging the suspension for 10 min at 50 g. The cells 
were rinsed twice, counted and cultured in 96-well culture plates (1 x 104 cells/O.1 
- - -
ml/well) for 3 h. The cells ' were rinsed briefly with warmed medium and cultured 
in the presence of pineal- indoles. The- activities oL glutamate-oxaloacetate 
transaminase and glutamate-pyruvate transaminase in the culture medium were 
determined as described by Reitman (1957). Cell viability was estimated by uptake 
of crystal violet. 
2.2.6 Statistics 
The Data was analyzed by one way analysis of variance using Scheffe's multiple 
21 . 
range test The levels of significance were taken at p < 0.05. 
2.3 Results 
Methoxytryptamine inhibited 3H-thymidine incorporation by mouse melanoma (B16) 
~ells with the highest potency (Figure 2.1). Marked inhibition of 3H-uridine 
incorporation (Figure 2.2) and 3H-leucine incorporation (Figure 2.3) by mouse 
melanoma cells was also achieved by methoxytryptamine. The effects of the other · 
indoles . were much weaker. 
Methoxytryptamine exhibited the highest potency -of inhibiting 3H-thymidine 
/ 
incorporation by sarcoma (S180) cells (Figure -2.4). The activities of most of the 
other indoles were weak up to 100 JlM. Serotonin and hydroxyindoleacetic acid had 
low potencies even at 500JlM . . 
Little inhibition « 20 %) of 3H-thymidine incorporation by PU5 cells in the presence 
of.-the various pineal indoles was observed up to an -indole concentration of 100: JlM 
(Figure 2.5). At 500 JlM concentration only methoxytryptamine demonstrated over 
90 % inhibition. 
At the concet.'ltration of 4 and 20 JlM hydroxytryptophol appeared to be the most-
potent inhibitory indole in the inhibition of 3H-thymidine incorporation by 
choriocarcinoma (Figure 2.6). At the concentration of 100 and 500 JlM serotonin 
appeared to be the least potent. All of the tested pineal indoles except serotonin and 
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hydroxyindoleacetic acid achieved over 90 % inhibition at the concentration of 500 
JlM. 
Methoxytryptamine exerted the most potent inhibitory effect (approximately 40 % 
inhibition at 100 JlM and .500 JlM) on crystal violet uptake by the fibroblast (3T3) 
cell line. The degree of inhibition achieved by the other pineal indoles was in 
general below 20% (Figure 2.7). 
The IDsos (dosages required to achieve 50% inhibition of cell -growth) of pineal 
indoles with regard "to various ~ell lines were shown in Table 1. The oraer of -
potency was methoxytryptamine » methoxytryptophol and hydroxytryptophol > 
/ 
melatonin and methoxyindoleacetic acid> serotonin and hydroxyindoleacetic acid~ 
When melatonin and methoxytryptamine were tested for possible toxic effects on rat 
hepatocytes in primary culture, it was found that the pineal indoles did not increase 
- . 
the release of glutamate-oxaloac~tate transaminase by hepatocytes into the culture 
medium (Figure 2.8). However, the release of glutamate-pyruvate transaminase was 
slightly enhanced (Figure 2.9). There was a slight inhibition of the uptake of crystal 
. ~ .. ! 
~ .. 
violet by both indoles (Figure 2.10). 
2.4 Discussion 
Melatqnin was found to have a low potency in suppressing the growth of the tumor 
cell lines. It is consistent with the findings of Boucek and Alvarez (Boucek 1970) 
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and Shellard (1989). Methoxytryptrumne exerted the highest potency in suppression 
of the growth of tumor cell lines. The demonstration of the suppressive effects of 
pineal indoles on in vitro 3H-thymidine incorporation by sarcoma and mouse 
melanoma cells in the present study is consistent with the findings reported by 
Bartsch and Bartsch (198~) and Narita and Kud~ (1985) that melatonin slowed down 
the growth of these tumor cell lines ' in vivo. · The inhibitory effect "of the pineal 
indoles on 3H-thymidine incorporation by choriocarcinoma cells is reminiscent of the 
action of melatonin on neoplasms in the female reproductive tract like ovarian 
carcinoma (Shellard et al., 1989) (lIld endometrial · cancer (Blask and Hill, 1986b). 
Hill (1986) observed that at low concentrations (1-100 nM), melatonin, N-
acetylserotonin and serotonin" did not affect proliferation of the murine 3T3 -cell line. 
Results of the present investigation are" in agreement with his data. 
Methoxytryptamine was the most potent inhibitory indole because it was still 
effective at the low concentration of 10 JlM on mouse melanoma and sarcoma cells. 
The present study revealed that methoxytryptamine was more potent than melatonin 
or .any other pineal indoles in inhibiting-the incorporation of ~H-thymidine in most 
tumor cell-lines. 
In previous studies methoxytryptamine has been shown to be more active than other 
pineal indoles in inhibiting LH -stimulated testosterone production by isolated rat 
Leydig cells (Ng and Lo, 1988), ACTH-stimulated corticosterone and aldosterone 
production by isolated rat adrenal c~lls (Ng, 1987), epinephrlne-stimulated lipolysis 
in isolated rat adipocytes (Ng and Wong, 1986) and spermatogenesis in hamsters-(Ooi 
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and Ng, 1989). Thus it is interest,ing to note that methoxytryptamine is the pineal 
indole with the highest cytotoxic effect on tumor cell lines. 
The demonstrated effect of pineal indoles on the tumor cell lines represents a direct 
cytotoxic action rather than an indirect one through their immunomodulatory action 
(Maestroni et al., 1986, 1987a, 1987b, ,1988). In the in vivo condition the antituinor 
action of melatonin (Blask and Hill, 1988) may be expressed through a direct 
cytotoxic effect and also through an indirect immunomodulatory effect. JP the 
present study reduction of incorporation of 3H-thymidine, 3H-uridine and 3H-Ieucine 
of tumor cell line af~er incubation with pineal indole may indicate inhibit~,?n of 
synthesis of DNA, RNA and protein. 
It is noteworthy that the pineal indoles did not exert significant toxic effects on 
isolated rat hepatocytes as reflected by results of the liver enzyme assays and dye 
uptake assays. 
Results of the present investigation are in general in support of evidence in ' the 
literature on the antitumor/oncostatic effect of pineal/melatonin. It has disclosed that 
melatonin is not the only antitumor indole elaborated by the pineal. Blask and Hill 
(1988) hold the opinion that melatonin constitutes a potentially useful substance for 
cancer chemotherapy. The other pineal indoles, perhaps 'methoxytryptamine, might 



















4 20 100 500 
Pineal Indole (Ji,M) 
Figure 2.1 Effects of pineal indoles on 3H-thymidine incorporation 
by mouse' melanoma (B 16) cells-- after 48 hours of 
incubation. Results are expressed as means + standard ' 
deviation -en = 3). SER = serotonin, MEL = melatonin, 
-HIA = hydroxyipdoleacetic acid,- MTP = methoxy -





















4 20 100- 500 
Pineal Indole (J.lM) 
Figure 2.2 Effects of pineal indoles on 3H-uridine incorporation by 
mouse melanoma (B16) cells' after 48 hours of 
incubation . • Results are expressed as means + standard 
deviation (ri = 3). SER = serotonin, MEL = melatonin, 
. HIA = hydroxyindoleacetic acid~ MTP = methoxy _. 
tryptophol, MT A = methoxytryptamine, MIA = 





















4 20 100 500 
Pineal Indole (p,M) 
Figure 2.3 Effects of pineal indoles on 3H~leucine ' incorporation 
by mouse melanoma (B 16) cells after 48 hours of 
incubation. Results are expressed as means + standar~ 
deviation (n "= 3). SER = serotonin, MEL = melatonin, 
. HIA = hydroxyindoleacetic acid,-~' MTP = methoxy -
tryptophol, ' MT A =methoxytryptamine, MIA = 




















4 20 100 500 
Pineal Indole (J.LM) 
' !' . Figure 2.4 Effects of pineal indoles on 3H -thymidine incorporation 
by sarcoma (SI80) cells after 4~ hours of incubation. 
Re~ults are expressed as means + standard deviation (n 
, 3) . . SER = serotonin, MEL = melatonin, iliA = 
hydroxyindoleacetic acid, MTP = methoxytryptophol, 
MT A = methoxytryptamine, MIA = methoxyindole-























4 20 100 500 
Pineal Indole (Ji,M) 
Figure 2.S Effects of pineal indoles on 3H-thymidine incorporation 
by macrophage-like (PUS) cells after 48 hours of 
inc~bation. Results are expressed as means + standard 
deviation (ri = 3). SER = serotonin, :MEL = melatonin, 
iliA = hydroxyindoleacetic acid" MTP = methoxy -
tryptophol, MT A = methoxytryptamine, MIA = 















4 20 100 -500 
Pineal Indole (JLM) 
Figure 2.6 Effects of pineal indoles on 3H -thymidine incorporation 
by choriocarcinoma (JAr) cells after 48 hours of 
incubation. Results are expressed as means + standard 
deviation (n = 3). SER = serotonin, MEL = melatonin, 
HIA = hydroxyindoleacetic acid,\ MTP = methoxy -
tryptophol, MT A = methoxytryptamine, MIA = 

























4 . 20 100 500 
Figure 2.7 Effects of pineal indoles on uptake of crystal violet by 
fibroblasts (3T3) after 48 hours 6f incubation. Results 
are .express~d as means. + standard deviation (n .. .3) . . 
SER = serotonin, MEL = melatonin, HIA = hydroxy -
indoleacetic acid, MTP = methoxytryptophol, MT A = 












VEH 20 100 500 
Pineal Indole (JLM) 
Figure 2.8 In vitro effects of melatonin and methoxytryptamine on 
release of glutamate oxaloacetate transaminase by a 
primary c~ture of rat hepatocytes. Results are 
expressed as means + standard deviation (n = 3). An 
asterisk. (*) denotes ' a statistically significant difference 
(p < 0.05) from control. VEH = control, MEL = 
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VEH 20 100- 500 
Pineal Indole (JLM) 
Figure 2.9 In vitro effects of melatonin and methoxytryptamine on 
release of glutamate pyruvate transaminase by a 
~ _ ,,_ primary culture of rat hepatocytes. Results are 
expressed as means + standard deviation (n =3). VEH 











4 20 100 500 
Pineal Indole (JLM) 
Figure 2.10 In vitro effects of melatonin and methoxytryptamine on 
uptake of crystal violet by a primary culture of rat 
. ~~L hepatocytes. Results are expressed as means + 
standard deviation (n = 3). VEH = control,. MEL = 
melatonin, MTA = methoxytryptariline. 
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Table 1 Doses of pineal indoles (JlM) required to achieve 50 % 



































SER = Serotonin, MEL = melatonin, HIA = hydroxyindoleacetic acid, 
MTP ' ~ methoxytryptophol~ MT A . = ' methoxytryptamine, MIA -
methoxyindoleacetic acid, RTP = hydroxytryptophol .~. 
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Chapter 3 Activation of murine peritoneal macrophages by melatonin and 
methoxytryptamine 
3.1 Introduction 
The suppressive effect of melatonin and methoxytryptamine on the growth of tumors 
has been demonstrated in the previous chapter. Earlier melatonin was shown to 
inhibit the growth of tumors including breast tumors (Karmali 1978), fibrosarcomas 
(Bartsch 1981), Lewis lung carcinomas (Lapin 1976), melanomas (Narita 1985, 
Stanberry 1983), marrimary tumors (Blask 1986), and prostatic carcinomas .tphilo 
1988, Toma 1987). Since involvement of macrophages in tumor growth- is well 
known, the possibility of an immunomodulatory effect· of melatonin and its 
derivatives on macrophages was hence studied. 
Tumoricidal activities of macrophages can be generally divided into antibody -
dependent cellular cytotoxicity (ADCC) and antibody - independent macrophage -
mediated tumor cytotoxicity (Fan 1991). This study focused-mainly on theantibo~y-
independent macrophage - mediated tumor cytotoxicity. · Macrophages can be 
activated by endotoxin and various cell mediators and regulators to kill tumor cells 
by pro~ucing tumor necrosis factor (Keller 1990), oxygen free radicals (Nathan 1980) 
and reactive nitrogen intermediates (Hibbs 1988~ Keller 1990). The intent of the 
present investigation was to ascertain if the pineal indoles, melatonin and 
methoxytryptamine, could affect the viability of macrophages and stimulate the 
production of tumor necrosis factor, superoxide, hydrogen peroxide and reactive 
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nitrogen intermediates by macrophages. The results would shed light on the 
mechanism of the antitumor effects of pineal indoles in vivo. 
3.2 Material and methods 
3.2.1 Chemicals 
Melatonin (MEL) , methoxytryptamine (MT A), lipopolysaccharide (LPS) from 
Escherichia coli, and phorboI12~myristate-13-acetate-4-0-methylester were obtained . 
from Sigma Chemical Co. Stocks of melatonin and methoxytryptamine ·were 
prepared by dissolving 50 mg pineal indole in 2 m1 95% alcohol. 
3.2.2 Culture media 
Dulbecco's modified Eagle's m~dium without phenol red (catalog no. D 2902), 
Dulbecco's phosphate buffered saline (catalog no. D 5652), Hank's balanced salts 
(catalog no. H 2387) and RPMI-1640 (catalog no. R 6504) were-purchased from 
Sigma Co. Generally, they were first unpacked and dissolved in 800 ml fresh 
double-distilled water. . They were stirred gently for 3 --- 4 hours. 2 g sodium 
bicarbonate was then 'added into the RPMI, 3.7 g sodium bicarbonate was added into 
the Dulbecco's modified Eagle's medium and 0.35 .g sodium bicarbonate was added 
into the Hank's balanced salt solution. 0.1 g MgC12-6 H20 and 0.133 g CaC12-2 
H20 were added into the Dulbecco' s phosphate-buffered saline. Each of the solutions 
was stirred for a few minutes and the pH was adjusted to 7.2 while stirring. Then 
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3.2.5 In vitro cytotoxicity of' melatonin and methoxytryptamine on mouse 
peritoneal macrophages 
Peritoneal macrophages from C57 mice were seeded into 96-well culture plates 
(Nunclon, Denmark) at a c9ncentration of 2 x 105 cells/0.1 ml/well and incubated at 
37°C in a humidified 95 % air - 5 % 'C02 atmosphere for 2 hours. The plate was 
washed with Hanks' balanced salt solution. Adherent macrophages were incubated 
with 125, 250 or 500 JlM pin,eal indole for 48 hours. Cells incubated with the. 
medium ~hich possessed the sa~e alcoholic concentration as the solvent for pineal 
indoles served as the control. After incubation for 24 hours, 'the culture was washed 
with phosphate - buffered salirie and then incubated with phosphate - buffere-d saline 
containing 0.005 % neutral red for 1 hour. The culture was then washed with 
phosphate buffered saline containing 1 % formaldehyde, 1 % CaCl2 and the 
remaining medium was drained. . After the culture was dried in air, the neutral red 
phagocytosed by the macrophages was extracted by ~he lysis buffer which contained 
1 % acetic acid - 50' % alcohol. The neutral red uptake of the macrophages , was 
determined using a micro~ELISAautoreader (3550 Bio-Rad microplate reader) at 540 
nm. Viability of the cells expressed as a percentage was calculated from the tatio of 
the absorbance of cells treated with pineal indole to the absorbance of control cells 
treated, with culture medium containing 0.38 % alcohol. 
3.2.6 Production and bioassay of tumor necrosis factor-a, (TNF-a,) 
Adherent peritoneal macrophages in 24-well culture plates (Nunclon, Denmark) at a 
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concentration of 2 X 106 cells/ml/well were obtained from mice treated with pineal 
indoles. The cells were cultured for 1, 2, and 4 hours in RPMI '1640 containing 1 
Jlg LPS /ml. The supematarit was collected and stored at - 70 QC for the L929 
bioassay~ 1 x 104 L929 fibroblasts /0.1 mlIwell were seated into 96-well ' culture 
plates (Coming, USA) and, ,incubated at 37 QC in a humidified 95 % air - 5 % CO2 
atmosphere for 24 _hours. ,The DNA synthesis of the L929 fibroblasts was arrested 
by incubating the cells with RPMI containing 5 Jlg actinomycin D (catalog no. A 
1410, Sigma) /ml for 2 hours. The L929 cells were then washed by Hanks' balanced 
salt solu~on and cultured with different dilutions of TNF-containing medium for 24 
. . 
hours. After incubation, the plates were washed in phosphate buffered saline arid the 
remaining cells were stained with crystal violet (0.5 % in methanol/water : 1/4 v/v) 
foi 3 minutes. The plates were washed with phosphate buffered saline several times 
and the medium was decanted. After the culture was dried in air, the macrophages 
were lysed by lysis buffer which contains 1 % acetic acid - 50, % alcohol. The 
quanti~y of crystal violet taken up by the macrophages was determined using a micro 
. ,. > - '- - -
ELISA autoreader (3550 Bib-Rad microplate reader USA) at 595 nm. 
3~2.7 Preparation ofTNF-a and Actin DNA probe (Sambrook et al., 1989) 
3.2.7.1)Preparation of the LJB agar 
10 g bacto-tryptone, 5 g bacto-yeast extract and 10 g NaCl were dissolved in 800 ml 
double distilled water. The pH was ,adjusted to 7.4, 15 g agar was added and the 
( volume was adjusted to 1 L. The solution was autoclaved, cooled down to 50 QC, 
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stirred gently, poured into 10 cm diameter petri dishes aseptically, and allowed to 
stand for 2 hours at room temperature before use. 
3.2.7.2 Preparation of LB· medium 
10 g bacto-tryptone, 5 g bacto-yeast extract, and 10 g NaCl were dissolved in 800 ml 
double distilled water. The pH was adjusted to 7.4 and the volume' to 1 L. The 
solution was autoclaved, cooled down at room temperature and then stored at 4 QC. 
3.2.7.3 Preparation . o/competent ceUs 
Es~herichia coli strain HB 101 cells were spread ·on LB agar and incubated at 37 QC 
overnight. One of the colonies was added to 5-ml LB medium and the tube was 
shaken overnight at 37 QC with a speed of 100 - 200 rpm. 1 ml of the overnight 
culture was pipetted into 99 ml LB medium and shaken at 37 QC for about 2 hours 
until the growth of the bacteria was at the log phase of their growth (the absorbance 
of the mixture at 550 nm was in the range 0.3 - 0.4). The culture was spun (2000 
g) at 4 QC for 10 minutes. The supematant was discarded and the pellet was 
resuspended in 50 ml ice - cold solution containing 50 mMCaCl2 and 10 mM Tris -
Cl at pH 8.0 in order to induce a transient state of "competence" in the recipient 
bacteria (increase the permeability of the cell wall), during which they were able to 
take up DNAs derived from a variety/ of sources. The solution was put on ice for 15 
minutes and spun at 4 QC for 5 minutes. The supematant was discarded and the 
'- pellet was resuspended in 6.67 ml ice - cold solution containing 50 mM CaCl2 and 
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10 mM Tris - Cl at pH 8.0. The competent cells can be stored at 4 QC for 24 hours. 
3.2.7.4 Transform.anon of plasmid 
0.5 ~l of the TNF-a (fro~ Dr. Beuder, Texas) or Actin (from Dr. C. C. Wong, 
C.U.H.K.) DNA probe containing plasmid, 9.5 JlI sterile distilled water, and 240 ~l 
competent cells were added to a 5 ml culture tube and put on ice for 10 minutes. 
The tube was incubated to 42 QC for 2 minutes and cooled down on ice ' after 
incubation. 0.75 ml LB medium ~as ,added, into the tube after the tube had been 
cooled down. The tube was then incubated at 37 QC for 1 hour. 
3.2~7.5 !Extraction of plasmid 
330 ~l of the transfonned HB 101 cells carrying the -plasmid of TNF-a or Actin 
DNA insert was spread on LB agar with ampicillin (50 mg ampicillin was added 
before the wann LB agar solution was poured into 10-cm diameter petri dishes) and 
incubated at 37 QC overnight. One of the colonies was ' added to 5 ml-LB medium 
and shaken overnight at 37 QC with a speed of 100 - 200 rpm. The culture was spun 
(2000 g) at 4 QC for 10 minutes. The supernatant was discarded and the pellet was 
resuspe~ded in-2.25 ml glucose buffer (25 mM Tris, pH 8.0, 50 mM glucose, and 10 
mM EDTA), which was isosmotic solution. 750 ~l fresh lysozyme solution (8 mg/ml 
glucose buffer) was added and incubated for 5 minutes at room temperature. The 
mixture was transferred to a 15 ml Corex centrifuge tube. 6 ml 0.8 % NaOH - 1 % 
SDS-was added into the tube in order to lyse the resulting spheroplasts to liberate the 
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plasmid from the pressurized interior of the bacteria. The tube was placed on ice for 
5 minutes. 4.5 ml ice-cold potassium acetate solution was added' and spun (12000 
g) at 4 QC for 10 minutes. The pellet was discarded and the supernatant was 
transferred into another Corex centrifuge tube. 7.5 ml isopropanol was added into 
the supernatant and the mixture was mixed by vortexing. The tube was placed in a -
20 QC freezer for 30 minutes. The tube was then spun (12000 g) at 4 QC for- 15 
,minutes. The supernatant was discarded and the pellet was resuspended in 800 J.ll 
Tris-EDTA buffer (10 mM Tris·Cl, 1 mM EDTA, pH 7.5). The solution 'was 
transferred to two 1.5 m1 microfuge tubes. 20 J.lg RNAase was added into each tube 
'to remove the RNA ' ~d the tubes were incubated at room temperature for 15 
minutes. The DNA in the solution was then extracted with 1 volume of phenol 
(equilibrated by 0.1 '% dehydroxyquinoline - l ' M Tris at pH 8.0), 2 volumes of 
phenol - chloroform - isoamyl-alcohol mixture (25 : 24 : 1 by volume) and 0.5 
volume of chloroform - isoamy-alcohol (24 : 1 by volume) successively to extract the 
protein because Escherichia coli ~train HB 101 cells was able to express endonuclease 
A, which degraded plasmid DNA during subsequent incubation in the presence of 
Mg++. The aqueous phase obtained after each extraction was transferred to a __ 2 _lnl 
microfuge tube. 1/10 volume of 3 M sodium acetate and '2.5 volumes of ice - cold 
ethanol were added. The DNA in the solution was then precipitated at - 70 QC for 
1 hour. After precipitation, the tubes were spun (12000 g) at 4 QC for 10 minutes. 
The solution was discarded and the pellet was resuspended in 1 ml 70 % alcohol. 
/ I 
The tube was spun (12000 g) at room temperatur~ for 3 minutes. The alcohol was 
discarded and the pellet was lyophilized for 10 minutes. The pellet was resuspended 
j n 10 J.lI Tris-EDTA (pH 7.5). 
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3.2.7.6 Separation of the DNA probe 
The extracted DNA was subjected to enzyme digestion. 0.5 volume of Pst I (catalog 
no. 140S,: New England Biolab, USA) and 0.5 volume of NEBuffer 3 (supplied with 
Pst I as 10 X concentratioQ . stock), 0.5 volume of BamH I (catalog no. 136S, New 
England Biolab, USA) and 0.5 volume 'of NEBuffer BamH I(supplied with BamH 1 
as 10 X concentration stock) and 7 volumes of double - distilled water were used to 
digest the DNA sample carrying the TNF-a DNA probe insert. Pst I alone was 'used 
to digest the. DNA sample carryin,g the actin DNA probe insert. The digestion was ' 
carried out at 37°C for at least 2 hours. Then the digested DNA was subjected to 
TAE agarose gel electrophoresis. 193.6 g Tris base, 108.9 g. CH3COONa.3 H20, and 
12.5 g EDTA-N~o2 H20 were dissolved in double - distilled water and the pH was 
adjusted to 7.2 with acetic acid and the volume to 1 L to serve as 40 X T AE. 9 
volumes of double distilled water and 1 -volume of loading buffer (5 ml glycerol, 250 
JlI 40 X T AE, 1 ml saturated bromophenol blue, 2.75 ml double distilled water were 
added together to make a 10 ml stock) were mixed with the extracted DNA and the 
mixture was incubated ·at 65°C for 2 minutes. It was then loaded-onto T AE agarose 
gel (prepared by dissolving 0.5 g agarose in the mixture· of 1 ml 50 X T AE, 5 JlI 
ethidium bromide, 49 ml double - . ~stilled water) using 1 X T AE as running buffer. 
Gel ele~trophoresis was run at 100 V until the front of bromophenol blue reached the 
positive pole. Because the size of the TNF-a DNA insert was about 1.3 kb and the 
size of the actin DNA insert was about' 1.8 - 2 kb, Lambda DNA BstE 11 was used 
as the marker DNA. 
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3.2.7.7 !Purification of the DNA probe 
After electrophoresis, the gel (only the area of the correspondent size) was cut and 
subjectedto DNA elution using Geneclean®11 kit (Bio 101 Inc., catalog no. " 3106). 
It was weighed and its volut:J1e was deduced by assuming that 1 g of the gel occupied 
a volume of about 1~. The cut gel was placed in a 2-ml microfuge tube and 
solubilized with 3 volumes of NaI (5.3 M so that the final concentration of NaI was 
above 4 M). The tube was incubated at 50 QC for 2 minutes. The tube was rrlixed 
thoroughly and incubated at 50 QC for 5 minutes. The gel was thus dissolved and 10 
Jll glassmilk (provided'in the Geneclean®II kit, generally 5 ; Jll for 5 "Jlg DNA,.,~"then 
1 Jll for each additional 0.5 Jlg DNA, but not harmful in excess) was added. The 
solution was mixed gently by pipetting up and down. The tube was put on ice for 
5 minutes to allow binding of DNA to the silica matrix. The mixture should be 
mixed every 1 - 2 minutes. Th~ tube was spun for a while. The . supernatant was 
better transferred to another microfuge tube for storage " so that it could be restored 
by another method when no DNA binding was found. The pellet was washed three 
-times with 200 - 700 Jll ice - cold NEW WASH (Bio 101, catalog no. 3109). The 
tube was spun for a while. The supernatant was discarded and tht? pellet was 
resuspended in Tris-EDT A buffer (same volume as that of glassmilk added). The 
mixtur~ was incubated at 50 QC for 3 minutes and spun for 30 seconds. The 
supernatant was collected and the pellet was washed once more with Tris-EDTA 
I 
" 
buffer. The supematant was collected. The purified DNA was stored at - 20 QC and 
was ready for hybridization. 
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3.2.8 Northern blotting technique for hybridization 
3.2.8.1 Isolation of total RNA 
Total RNA was extracted ac~ording to the method of Chirgwin et al (1979). Briefly, 
4 X 108 peritoneal macrophages /10 ml/plate, similarly stimulated by LPS, were 
cultured in a 10-cm diameter culture dish (Falcon) for extraction of total cellular 
RNA after 0.5, 1 and 2 hours. The cells were lysed using 3 ml of 50 mM Tris buffer 
(pH 7.5) containing 5 M guanidinium thiocyanate, 10 mM EDTA and 8 % 2 -
mercaptoethanol. 21 ml of 4 M lithium chloride was added to protect the RN~.,from 
RNAase. The" lysate was incubated at 4 °C overnight and then spun (10000 g) 
(Beckman) at 4 °C for 1 hour. The pellet was resuspended in 5 ml of 3 M lithium 
chloride and spun (10000 g) at 4 °C for 20 minutes. The pellet was resuspended in 
1 ml solubilization buffer (10 mM Tris, pH 7.5, 1 mM EDTA, 0.1 % SDS). The 
mixture was frozen in liquid nitrogen and vortexed while thawing. The mixture was 
then transferred to a 2-ml microfuge tube and extracted with 0.7 - 0.8 ml phenol. It 
was spun (12000 g) at room temperature for 3 minutes. The aqueous phase-was 
transferred into another tube and " extracted with 0.7 - Q.8 rill phenol-chlorofonn-
isoamyl alcohol mixture (25:24:1 by volume). It was spun (14000) rpm at room 
temperature for 3 minutes. The aqueous phase was transferred into another "tube and 
extracted with 0.7 - 0.8 ml chlorofonn - isoamyl alcohol (24: 1 by volume). The tube 
was spun (12000 g) at room temperature for 3 minutes. The aqueous phase was 
transferred into another tube and 0.1 ml 5 M NaCI and 0.9 ml isopropanol were 
added to the aqueous phase. The tube was then left at - 70°C for 1 hour. The tube 
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was spun (12000 g) at 4 °C for 10 minutes. The solution' was discarded and the 
pellet was resuspended in 1 m1 70 % alcohol. The tube was spun (12000 g) at room 
temperature for 3 minutes. The alcohol was discarded and the pellet was lyophilized 
for 10 minutes. The pellet was resuspended in 10 ~l Tris-EDTA (PH 7.5),~ The 
quantity of RNA was then determined by measuring the absorbance at 260 nm. 
3.2.8.2 Separation of RNA 
The isolated total RNA was then loaded on 1 % formaldehyde gel for electrophoresis. 
. -' 
The 1 % formaldehyd~· gel was prepared by dissolving 0.5 . g agarose in 36.0~:_ rn1 
DEP H20 (prepared by autoclaving a 0.1 % diethylpyrocarbonate solution, bQiling it 
to expel the DEPC until there was no smell of DEPC), 5 rn1 10 X MOPSIEDTA 
(41.8 ' g morpholinopropane-sulfonic acid, 6.8 g sodium acetate, and 3.8 g tetrasodium 
EDT A salt were dissolved in 1 L double distilled water, pH 7.0),8.93rn1 
formaldehyde, and 5 ~l ethidium bromide. The running buffer was 250 ml 1 X 
MOPSIEDTA. The loading buffer was a mixture of 150 ~l 10-fold dye (50 % 
glycerol + i mM . EDTA, pH 7.4 + 0.4 % bromophenol blue), 150· ~l 10-fold 
MOPSIEDTA, 255 ~l 37 % formaldehyde, 750 ~l fo~amide . . 6.67 volumes of 
loading puffer was mixe~ with 20 ~g RNA. It was incubated at 65 QC for 2 minutes 
. and cooled-down in ice. It was spun down and loaded into the wells . of the 1 % 
formaldehyde geL It was then run overnight at 12 V from the negative pole to the 
positive pole. 
3.2.8.3 Northern blotting 
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The gel was exarrllned under an ultraviolet illuminator to visualize the separation. 
18 S and 28 S RNA should be seen. The left corner of the fIrst lane was cut for 
marking the location of the first lane. The gel was then ready for blotting. A Zeta 
Probe membrane (Amersham) with a size similar to that of the gel was first soaked 
. , 
in distilled water and then in 10 X SSC (87.65 g NaCI, 44.1 g sodium citrate in 1 L 
double distilled water, pH 7.0, sterilized) for 30 minutes. Two filter papers (3 mm) 
were used to prepare the paper bridge by soaking in 10 X SS C. The soaked filter 
papers were put on--i the plastic bridge which was located on top of a tank contaiping 
200 ml 10 X SSC. The gel was put upside down on the paper bridge. The soaked 
Zeta Probe membrane ~as cut at one of the corners and put on the gel so that th~:_ cut 
corner of the membrane matched the cut corner of the gel. The tank w~s then 
wrapped by cling wrap to avoid evaporation of 10 X SSC. The edge of the cling 
wrap should be folded for more powerful isolation. Four filter papers were cut to 
a size similar to that of the gel and 2 of them were soaked in 10 X SSC. The 2 wet 
filter papers were put on the Zeta Probe membrane first arid 2 dry filter papers were 
put on top of the deck. A .deck of paper · towel was added on the -deck. A-50U-g 
weight was put on top of the deck to induce a capillary force which made the 10 .X 
SSC move on to the filter paper, pass through the gel, and co'nduct the content of the 
gel to move toward the membrane. After overnight transfer, the gel and the blot 
, . . 
were examined under a ultraviolet illuminator to see whether the transfer was 
complete. The blot was washed in 50 ml 2 X SSC for 30 minutes. The blot 'was 
cross - linked at 0.12 J/cm2 by a ultraviolet cross - linker (Spectrolinker XL 1500 UV 
Crosslinker, Spectronics Corporation) 2 times. The blot was then wrapped by two 
filter papers in the plastic bag for storage at room temperature. 
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3.2.9 Hybridization ofTNF-a mRNA and Actin mRNA 
3.2.9.1 Prehybridization 
The buffer used for pre-hybridization was FSSSE (7 g SDS in 100 ml mixture 
containing 50 ml of 100 % fonnamide,25 ml of 1 M NaHP04 at pH 7.2,5 ml of 5 
M NaCl, and 0.5 ml of 0.5 M EDTA at pH 8.0, 19.5 ml double distilled water). The 
blot was put into a bottle and 5 ml FSSSE was pipette into the bottle. The bottle' was 
put into a rotating incubator w~ich was maintained at 42°C so that each part of the 
blot could be soaked thoroughly. After overnight pre-hybridization, the blot~~was · 
ready for hybridization. 
3.2.9.2 Probe labe lUng 
The TNF-a probe and actin probe were labelled with 32p-dCTP by random priming. 
2 III TNF-a DNA probe containing 100 ng DNA was added into an eppendorf tube. 
5 Ill -double-distilled water and 1.25 III 0..1- ·U /IlLhexamer (Phannacia .. 27 -2166-01 
random primers) were then added. The mixture was then boiled for 2 minutes and 
transferred to ice immediately. It was spun down by brief centrifugation at 3000 
rpm. ~ III bovine serum albumin (10 mg/ml) , 5 III 32p-dCTP, 0.75 III klenow 
fragment (5000 U/ml, Phannacia 27-0928-02) and 10 III reaction buffer (mixture of 
0.5 M Hepes at pH 6.6, ·12.5 mM MgCI2, 0.025 M B - mercaptoethanol, 0.125 M Tris 
. pH 8.0, 50 IlM dA TP and 50 IlM dG~, 50 IlM dTTP) were added, bringing the total 
volume to 25~. The reaction was then allowed to proceed at 37°C for 3 hours . 
.> 
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A Sephadex G50 gel column was packed in a 1-ml syringe before the reaction was 
. . 
completed. After completion of reaction, the reaction mixture was loaded onto the 
column with 150 J.lI 10+ 1 TE - 0.1 % SDS (mixture of 5 ml of 2 M Tris at pH 7.5, 
,-
0.4 ml of 0.25 M EDTA, 1 ml of 10 % SDS and 93.6 ml of double distilled water). 
It was spun down and collected in an eppendorf tube which was put into the test tube 
before loading. 1 J.lI reaction mixture was then pipetted into an empty scintillation 
counting vial. The radioactivity of the labelled probe was then measured with a 
Beckman B-counter. The amount of the labelled probe used was about 1 million cpm 
per lane . . 
3.2.9.3 Hybridization 
The pre-hybridization buffer in the bottle was replaced with 5 ml fresh FSSSE after 
rolling ·at 42 cC. A suitable amount of 32P-dCTP labelled TNF-a or actin DNA 
probe was added into the bottle. The hybridization mixture was then rolled at 42 cC 
overnight. 
3.2.9.4 A7J4torooiography 
After complete hybridization, the blot was washed with 0.1 % SDS - 2 X SSC 
solution 3 times. The blot was transferred . to room temperature and shaken in 0.1 % 
SDS .:. 2 X SSC solution at a speed of 236 rpm for 15 minutes. The blot was then 
shaken in 0.1 % SDS - 0.2 X SSC solution for 15 minutes. The blot was finally 
shaken twice in 0.1 % SDS - 0.1 X SSC solution at 37 cC for 15 minutes. A low 
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count of the blot was preferred because the non - specific binding can always be 
washed away. If the count was still high, increasing the temperature should help to 
solve the problem. The washed blot was wrapped using saran wrap. The wrapped 
blot was then exposed to a Kodak XAR - 5 film at - 70 QC for 1 day. After the film 
was exposed, it was developed in developer (5-fold dilution of developer of Kodak, 
-A~stralia, catalog no. 405 1298) for 5 minutes, rinsed with water, fixed in fixer (4-
fold dilution of liquid x-ray fixer and replenisher of Kodak, Australia, catalog no. 405 
1611) for 5 minutes, rinsed with water and then air - dried. The autoradiogram was 
scanned with a desitoineter. (GS ' 3000 . TransmittancelReflectance Scanning 
Desitometer, Hoefer Scientific Instruments) to compare the band intensities. The 'blot 
was then shaken in 0.1 % SDS - 0.1 X SSC solution at 95 QC for 15 - 30 minutes to 
wash away the DNA ·'probe. The washed blot was then ready for other 
hybridizations. 
3.2.10 Assay for nitrite production by peritoneal macrophages 
Nitrite is a stable -metabolite of reactive nitrogen intermediate. The Griess reaction 
is a specific and sensitive test for nitrite (Hibbs 1988). Nitrite reacts in acid solution, 
by intermediate formation of nitrous acid, with primary aromatic amines (for 
example, naphthalene-ethylenediamine) form diazonium compounds which are able 
of coupling with amino or hydroxy derivatives (for example, sulfanilamide) to form 
azodyes (for example, naphthalene-ethylenediamine-p-azobenzene-sulphonic acid) . 
. Thioglycolate - elicited peritoneal macrophages were collected and washed with 
Hanks '---balanced salt solution. They were resuspended at a concentration of 2 X 106 
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cells/ml supplemented DMEM without phenol red. The cells were allowed to adhere 
onto the surface of a 96 - well culture plate for 2 hours before they were challenged 
with lipopolysaccharide ~1 J-lg/ml) for 1 day. The supernatant was then allowed to 
react with half its volume of Griess reagent (1 % sulfanilamide in 5 % H3PO~ - 0.1 
% naphthalene-ethylenedianUne dihydrochloride) for 15 minutes and the nitrite 
present in,- the culture medium was measured with an ELISA reader at 540 nm. The 
concentration of ~itrite was estimated using NaN02 as the standard and expressed in 
J-lM. 
, '.l ,. 
3.2.11 Assay for production of reactive oxygen intermediate ( superoxide anion} by 
peritoneal macrophages 
The method is the reduction of ferricytochrome c by O2-, a process in which O2-
serves as an electron donor (Edgar 1981). Amount of reduced cytochrome C is 
determined by measuring its absorbance at 550 nm. Peritoneal macrophages at a 
concentration of 2 X 1 06 cells~~ were cultured in phosphate buffered saline 
supplemented with 1 g glucose/L and 80 J-lM cytochrome-C. (Sigma.C2506, Type Ill) -
I 
and stimulated simultaneously with 200 nM phorbol 12~myristate-13-acetate-4-0-
methylester (Sigma, catalog no. P8139). The cells were incubated at 37°C for 1 
hour. The reaction was stopped by placing the mixture in ice. The amount of 
superoxide anion released into the -culture medium was calculated from the extinction 
coefficient by-the formula As50nm X light path (cm) = 21 x 103 M-I and the superoxide 
concentration was expressed in JlM. ' 
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3.2.12 Assay for production of hydrogen peroxide by peritoneal macrophages 
The method is based on the horseradish peroxidase-dependent oxidation of phenol 
sulfonphthalein, which is also known as phenol red (Edgar 1981). The composition 
of PRS (phenol red solution)" assay medium is 8.18 g/L NaCI, 0.99 g/L glucose, 0.2 
g/L phenol red, 19000 U/L horseradish peroxidase (Sigma P-8125, Lot 15F-8520), 
and 10 mM potassium phosphate buffer at pH 7.0 (0.136 g KH2P04 and 0.276 g 
N~HP04 'H20 dissolved in 200 ml double distilled water with the pH adjusted to 7.0 
and the volume to 255 ml). Peritoneal macrophages at a concentration of 2 X 106 
cells/ml were cultured in PRS and stimulated with 200 nM phorbol12 - myristaie-13 
- acetate 4 -0 - methylester at 37 QC for 1 hour. The reaction was stopped by 
addition of 1/10 volume (10 ~l) of 1 N NaOH. · The absorbance at 600 nm was 
measured. The concentration of H20 2 was calculated using serial dilutions of 30 % 
H20 2 (Merck Art. 8597) as standard and-expressed in ~M. 
3.2.13 Treatment of peritoneal macrophages with pineal indole in vitro followed 
by measurement of production of nitrite, superoxide or hydrogen peroxide 
by peritoneal macrophages in vitro 
~ 
Adherent peritoneal macrophages were incubated . with melatonin or 
methoxytryptamine at a concentration of 0~5, 5, or 50 ~M for 48 hours. The culture 
medium was decanted and the macrophages were washed with phosphate buffered 
saline. The macrophages were then stimulated with lipopolysaccharide (1 ~g/ml for 
1 day) or phorbol 12-myristate-13-acetate-4-0-methylester (200 nM for 1 hour). In 
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the case of lipopolysaccharide stimulation, Griess reagent was added to react with 
nitrite present in the culture medium. In the case of phorbol ester stimulation, the 
culture medium was taken for superoxide measurement or for hydrogen peroxide 
detenninaHon after addition of 1 N NaOH to terminate the reaction as detailed 'above. 
3.2.14 Statistics 
The data were analyzed by one way analysis of variance using Scheffe' s multiple 
range test. The levels of significance were taken at p < 0.05. 
3.3 Results 
3.3.1 In vitro effects of melatonin and methoxytryptamine on viability of 
peritoneal macrophages from C57 mice 
Adherent peritoneal macrophages from normal C57 lTIlce were incubated with 
melatonin or methoxytryptamine at a. concentration of 125, 250, 500 ~M for 48 
hours. The cell viability is shown in Figure 3.1. Although slight decreases in cell 
i 
viability were found when the dose of melatonin or methoxytryptamine was 
increased, about 95 % of the cells were still viable at the highest concentration of 
pineal indoles tested. Thus melatonin and methoxytryptamine exerted only a slight 
cytotoxic effect on normal peritoneal macrophages at high concentrations. 
3.:'.2 _  In vitro effects of melatonin and methoxytryptamine on nitrite production by 
55 
peritoneal macrophages from C57 mice 
Melatonin or methoxytryptamine at a concentration of 0.5, 5, or 50 ~M was 
incubated with adherent peritoneal macrophages for 48 hours. . The concentrat~on of 
nitrite released into the cult~e medium was calculated from the NaN02 standard 
curve (Figure 3.2). Melatonin at 5 JlM and methoxytryptamine at 0.5 ~M were found 
to enhance nitrite production (24 JlM and 30 ~M respectively) (Figure 3.3). Both 
melatonin and methoxytryptamine exerted a smaller enhancing effect on nitrite 
production when their concentration was increased. The nitrite level returned to the 
control level when t4e indole concentration was increased to 50 ~M. .:The 
concentration of nitrite produced by stimulated peritoneal macrophages of control 
mice was about 16 JlM. 
3.3.3 In vitro nitrite production by peritoneal macrophages from C57 mice which 
had been treated with melatonin or methoxytryptamine in the drinking water 
(100· ~g/ml) for 2 weeks· 
Peritoneal macrophages isolated from melatonin - and mythoxytryptamine - treated 
inice /produced a higher level of nitrite when compared to the control (Figure 3.4). 
Melatonin - treated mice produced a 2 - fold higher level of nitrite than the control 
group. Methoxytryptamine - treated mice produced only a slightly higher nitrite level 
than the control group. The concentration of nitrite produced by stimulated peritoneal 
macrophages from control mice w,as about 8 ~M. 
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3.3.4 In vitro effects of melatonin and methoxytryptamine on hydrogen peroxide 
production by peritoneal macrophages from normal CS7 mice 
The concentration of hydrogen peroxide released into the culture medium was 
calculated from the H20 2 sta!ldard curve (Figure 3.5). The results are presented in 
Fi~ure 3.6. Hydrogen peroxide production decreased, although not significantly, 
when the dose of melatonin was increased. The production of hydrogen peroxide 
decreased by about 50 % in the presence of 0.5 J.lM methoxytryptamine and by about 
60 % when the dose of metho~ytryptamine was increased to 50 J.lM. The decrease 
in production of hydrogen peroxide in response tomethoxytryptamine -treatment.was 
significant. The concentration of hydrogen peroxide produced by the stimulated 
peritoneal macrophages in the control was about 1.4 J.lM. 
3.3.5 In vitro hydrogen peroxide production by peritoneal macrophagesfrom CS7 
mice which had been treated with melatonin or methoxytryptamine in the 
drinking water (100 J.lg/ml) for 2 weeks 
..... 
The results are presented in Figure 3.7. Peritoneal macrophages isolated from 
melatonin - treated mice produced more hydrogen peroxide but the increase. was-not 
significa~t. Peritoneal macrophages isolated from methoxytryptamine - treated mice 
produced less (about 40 % less than the control level) hydrogen peroxide. . The 
concentration of hydrogen peroxide produced by -peritoneal macrophages from the 
control mice was about 2 J.lM. 
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3.3.6 In vitro effects of melatonin and methoxytryptamine on superoxide 
production by peritoneal macrophagesfrom C57 mice . 
The results are presented in Figure 3.8. Melatonin and methoxytryptamine at a 
concentration of · 0.5 JlM iQcreased superoxide production by about 15 %. No 
significant changes were produced at higher concentrations · of both pineal indoles. 
The concentration of superoxide produced by stimulated peritoneal macrophages from 
_ control mice was about 4.5 JlM. 
3.3.7 In vitro superoxide production by peritoneal macrophages from C57 mice 
which had been treated with melatonin or methoxytryptamine in the drinking 
water (100 J,1g/ml) for 2 weeks 
The results are presented in Figure 3.9. Peritoneal macrophages isolated from 
melatonin - treated mice produced 20 % more superoxide than those from control 
mice and the difference was significant. Peritoneal macrophages isolated from 
methoxytryptamine - treated mice produced 30 % less superoxide than cells of control 
- mice and the · difference was also significant. The concentration of superoxide 
/ 
produced by stimulated peritoneal macrophages from control mice was about 12.5 
3.3.8 In vitro effects of melatonin and methoxytryptamine (50 ~) on production 
of tumor necrosis factor-a, by peritoneal macrophages from C57 mice 
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The results are presented in Figure 3.10. The L929 bioassay is a sensitive test for 
tumor necrosis factor-Cl. The ,larger the amourit of tumor necrosis factor-Cl, the 
greater is the inhibition of growth of L929 cells. The secretion of tumor necrosis 
factor-Cl by'lipopolysaccharide - stimulated macrophages increased as the duration of 
stimulation increased from 1 hour to 4 hours. The tumor necrosis factor-Cl containing 
supematant was diluted 200 folds for assay. Generally speaking, there was little or 
no difference in the ability to produce tumor necrosis factor-Cl between macrophages 
from control mice and those from melatonin - treated or methoxytryptamine - treated 
truce. Although there was less tumor necrosis factor-Cl produced by macrophages of 
methoxytryptamine - treated mice when compared to those from control mice after 
4 hours of LPS stimulation, the difference was only about 6 %. 
3.3.9 In vitro production of tumor necrosis factor-Cl by peritoneal macrophages 
from C57 -mice which -had been treated with melatonin or 
methoxytryptamine in drinking water (100 J.lg/ml) for 2 weeks. 
The tumor necrosis factor-Cl-containing supematant was diluted 200, 400, 800 fold~ 
for assay. The results are presented in Figure 3.11, 3.12, and 3.13 respectively. The 
I 
level of tumor necrosis factor-Cl was found to be higher (less than 10 % ,difference 
in both ~ases) in macrophages from melatonin - treat,ed or methoxytryptamine ... 
treated mice than those from control mice after 4 hours of LPS stimulation using a 
dilution of 1 : 200 for the supernatant (Figure 3.11). The level of tumor necrosis 
factor-a was found to be higher (about 10 % and 5 % respectively) in macrophages 
, from melatonin - treated or methoxytryptamine - treated mice than those from c,ontrol 
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mice after 4 hours of LPS stimulation using a dilution of 1 : 400 for the supernatant 
(Figure 3.12). The level of tumor necrosis factor-a. was found t6' be higher (about 
1 fold after 2 hours and about 1.5 folds after 4 hours in the case of melatonin -
treated macrophages, and about 1.8 folds after 2 hours, about 2 folds after 4' hours 
in the case of methoxytryptamine - treated macrophages) in macrophages from 
~elatonin - treated or methoxytryptamine - treated mice than those from control mice 
after 2 and 4 hours of LPS stimulation using a dilution of 1 : 800 for the supernatant 
(Figure 3.13). 
3.3.10 Ratio of tumor necrosis factor-a. (TNF-a.) messenger RNA to actin 
messenger RNA in macrophages from CS7 mice which had been lreated 
with melatonin or methoxytryptamine in the drinking water for 2 weeks after 
treatment with lipopolysaccharide (LPS) for different durations. 
The result of Northern blot hybridization is shown in Figure 3.14 and Figure 3.15. 
The ratio of TNF-a. rilRNA to actin rilRNA increased when the duration of lipo -
polysaccharide stimulation was .. increased from 30 minutes to 120 minutes. 
Macrophages from melatonin - treated mice possessed a 25 % higher TNF-a. rilRNA 
level than macrophages from control mice after 30 minutes of LPS stimulation and 
a slightly lower TNF-a. mRNA level than macrophages from control mice after 60 
and 120 minutes of LPS stimulation. Macrophages from methoxytryptamine - treated 
mice exhibited a slightly lower TNF-a. mRNA level than macrophages from control 
mice after 60 minutes of LPS stimulation and a slightly higher TNF-a. rilRNA level 
than macrophages from control mice after 120 minutes of LPS stimulation. 
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3.4 Discussion 
The existing literature points to an immunostimulatory effect of melatonin. J ankovic 
et al (1970) observed that pinealectomy induced an impainnent of immune potential. 
Administration of the B - adrenergic antagonist, propranolol, which inhibits melatonin 
synthesis, ensued in diminished primary and secondary humoral responses (Maestroni 
and Pierpaoli, 1987). 
The present study showed that there was a correlation between the . actions of 
melatonin on the production of hydrogen peroxide and nitrite by peritoneal 
macrophages in vivo and in vitro. A similar observation was also made regarding 
-. 
the effect of methoxytryptamine on generation of hydrogen peroxide, nitrite and 
superoxide. However, a discrepancy was detected between the in vivo and in vitro 
actions of melatonin on tumor necrosis factor-a, production and those of 
methoxytryptamine on production of tumor necrosis factor-a, and superoxide. The 
discrepancy noted in the case of tumor necrosis factor-a, production was probably due 
to the fact that in the in vivo study the macroph~ges had been primed or stimulated 
for a longer duration by lymphokines produced in response to pineal indole and they 
subsequently demonstrated a greater response to the stimulant in vitro. The 
discrepancy seen in the effect of methoxytryptamine on superoxide production is 
more difficult to explain. 
There were similarities and differences between the actions of melatonin and 
methoxytryptamine on peritoneal macrophages. Both indoles enhanced nitrite 
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production in vivo and in vitro, superoxide production in vitro and tumor necrosis 
factor-a. production in vitro. On the other hand, methoxytryptamine manifested a 
distinct suppressive action on hydrogen peroxide production under both in vivo and 
in vitro conditions whereas melatonin did not evoke a significant change under either 
condition. Furthermore, while melatonin increased superoxide production in vivo, 
methoxytrypt~ne pr9duced a change in the opposite direction. How these 
differences in actions between the two pineal indoles are related to their structural 
differences remain to be elucidated in a more extensive investigation in the future. 
The lack of an adverse effect of melatonin and methoxytryptamine on the viability 
. . : .. ~' 
of peritoneal macrophages supports the meaningfulness of the data obtained ~n· the 
present study. 
Ding (1988) reported that incubation of macrophages with ,,(-interferon for 48 hours 
in the presence of lipopolysacc~aride inhibited hydrogen peroxide production but 
augmented nitrite release. Similarly, in the present study methoxytryptamine 
. . 
treatment evoked an · increase in nitrite . production and a decrease in hydrogen 
, . 
peroxide production, and melatonin treatment elicited a rise in nitrite production .but . 
did not produce a rnarked change in hydrogen peroxide .. Ding (1988) made three 
suggestions with references to , ~is findings. Firstly, ,,(-interferon was the only 
cytokine tested able to· induce both hydrogen peroxide and nitrite release. Secondly, 
the secretion of hydrogen peroxide and the secretion of nitrite involve two 
independent pathways. ~ Thirdly, combination of lipopolysaccharide and a./B/"( .-
. interferon or tumor necrosis factor-a/B and ,,(-interferon can induce nitrite secretion 
synergistically. Hibbs (1987) proposed that arginine deiminase converted L - arginine 
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into L - citrulline and ammonia. Affimonia was then oxidized to form nitrite. Stuehr 
(1989) claimed that reactive radical nitric oxide, which was" produced during 
metabolism of L - arginine to N02-/N03-' was the mediator of macrophage - induced 
cytostasis~' Keller (1.990) proved' that reactive nitrogen intermediates were the main 
effectors against tumor n~crosis factor-a resistant tumor cells. Keller (1990) 
, s~lggested that the mechanisms of tumoricidal activities of activated macrophages 
were reliant on the type of tumor cells and the pathway of macrophage activation. 
The' ability of melatonin and methoxytryptamine to elevate -nitrite production by 
peritoneal macrophages is thus in line with the in vitro cytotoxic action of the indoles 
on tumor cells. 
A sharp increase in oxygen consumption was found after stimulation of phagocytes 
(Babior 1978). Sbarra and Kamovsky (1959) showed that oxygen consumed in the 
respiratory burst of phagocytes was not used for energy production since inhibitors 
of mitochondrial respiration did not decrease oxygen consumption. Babior (1978) 
suggested that the oxygen consumed was reduced to superoxide by NADPH oxidase 
which in turn oxidized NADPH 'to NADP+. The- increase-in NADP+ -- led' to an 
activation -- of the hexose monophosphate shunt which subsequently reduced NADP+ 
to NADPH which serves-as the electron donor of oxygen. Superoxide dismutase then 
convert~d thesuperoxide into hydrogen peroxide. Useless hydrogen peroxide was 
used to oxidize the reduced glutathione by glutathione peroxidase. Oxidized 
glutathione was then reduced by glutathione reductase which used NADPH as the 
electron donor. The glutathione perpxidase - glutathione reductase system hence 
provided more NADP+. Superoxide and hydrogen peroxide can break_the bonds in 
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proteins, lipids and nucleic acids and oxidize various bonds such as disulfide bonds 
in enzymes (Natban 1980). The ability of melatonin to elevate superoxide production 
by peritoneal macrophages was less obvious while superoxide production was 
lowered after methoxytryptamine treatment. A similar obseIVation was i made 
regarding the effects of m~latonin and methoxytryptamine on hydrogen peroxide 
. production. Superoxide and hydrogen peroxide hence appear to contribute little to 
the enhancement of tumoricidal activity of peritoneal macrophages by pineal indoles. 
Another important effec'tor was tumor necrosis factor-a. Beritler '(1991) reported-the 
tumor necrosis factor-a gene . has been silenced in non - macrophage cell lines. 
Tumor necrosis factor-a has been reported to cause prolonged inhibition of tumor 
growth in the absence of T - cell immunity without causing severe weight loss or 
rapid development of resistance' of the tumorto the growth inhibitory. effects oftumor 
necrosis factor-a (Teng 1991). Kronke (1990) pointed out that tumor necrosis factor-
a has been reported to induce genes encoding soluble factors such as collagenase, 
prostaglandin E2, granulocyte-macrophage colony stimulating- factor, ' interleukin~~, 
and tumor necrosis factor-a itself. Tumor necrosis factor-a also enhances the 
expression of the human leukocyte antigen - A, B, C and D and the receptor of 
interleukin-2. Tumoi necrosis factor-a induces c-myc, c-fos, c-jun which are genes 
encoding nuclear antigens. Tumor necrosis factor-a inhibits c-myc expression in some 
tumor cell lines sensitive to the growth inhibitory action of tumor necrosis factor-a. 
Reid (1989) suggested that there were at least 2 mechanisms of tumor necrosis factor-
a . mediated cell killing. Cycloheximide is well known to enhance turilor necrosis 
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factor-a - mediated cell killing in culture. Reid found that using a combination of 
tumor necrosis factor-a and cycloheximide to treat tumor cell lines' yielded 2 different 
results. . Some of them were susceptible to the action of the combination. Others 
were resistant to the combination and were susceptible to tumor necrosis factor-a 
only. Strieter (1989) suggested that interleukin-2 was important for the induction of 
tQe tumor necrosis factor-a gene expression by both normal peritoneal and alveolar 
macrophages. 
In the present investigation, the observatio~ of an augmented production of . tumor 
necrosis factor-a mRNA and tumor necrosis factor by macrophages from mice tre'ated 
with melatonin and methoxytryptamine is consistent with the finding of in vitro 
cytotoxic action of melatonin and methoxytryptaniine against tumor cell lines. Thus 
it appears that the pineal indoles can combat tumor cells directly as well as indirectly 
via an· action on macrophages . . An inununostimulatory role of methoxytryptamine is 
disclosed in addition to a similar function of melatonin which has also been suggested 
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In vitro effects of melatonin and .methoxytryptamine 'on 
nitrite production by peritoneal macrophages from C57 
mice. Results are expressed as means + standard 
deviation '(n = . 3). An asterisk (*) denotes· a 
statistically significant difference (p < 0.05) from 
control. VEH" = control, MEL = melatonin, MTA = 
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Figure 3.4 In vitro nitrite production by p,eritoneal macrophages 
from C57 mice (~ = 20/group) treated with melatonin 
or . methoxytryptamine in the drinking water (100 
Jig/ml) for 2 weeks. Results are expressed as means + . 
standard deviation (n = . 3). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 
control. A cross (+) denotes a statistically significant 
difference (p < 0.05) from melatonin group. VEH = . 
control, ·MEL = melatonin, MT A = methoxytryptamine. 
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Figure 3.5 Standard curve for hydrogen peroxide assay usmg 
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Figure 3.6 In vitro effects of melatonin and Plethoxytryptllinine on 
hydrogen peroxide production by peritoneal 
macrophages from C57 mice. Results are expressed as 
means + standard deviation (n = 3). An asterisk (*) 
denotes a statistically' significant difference (p < 0.05) 
from control. A cross (+ ) . denotes a statistically 
significant difference (p < 0.05) from corresponding 
melatonin group. VEH = control, MEL = melatonin, 
MT A = methoxytryptamine. 
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Figure 3.7 In vitro hydrogen peroxide prqduction by peritoneal 
macrophages from C57 mice (N = 20/group) treated 
with melatonin or methoxytryptamine in the drinking 
water (100 J.lg/rnl) for 2 weeks. Results are expressed 
as means + standard deviation (n = 3). An asterisk (*) 
denotes a statistically significarit difference (p < O~05) 
from control. . . A cross (+ ) denotes a statistically 
significant difference (p < 0.05) from melatonin group. 
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-Figure 3.8 In vitro effects of melatonin and methoxytryptamine on 
superoxide production by peritoriealmacrophages from 
C57 mice. Results are expressed as means + standard 
deviation (l1 = 3). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 


















VEH MEL MTA 
. Figure 3.9 In vitro superoxide production . by peritoneal 
macrophages from C57 mice (N = 20/group) treated 
wit~ melatonin or methoxytryptamine in the drinking 
water (100 J.lg/ml) for 2 weeks. Results a~e expressed 
as means + standard deviation (n = 3). An asterisk (*) 
denotes a statistically significant difference (p < 0.05) 
from cqntrol. A cross (+ ) denotes a statistically 
significant difference (p < ,0.05) from melatonin group. 
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Figure 3.10 In vitro· effects of ' melatonin ' .. (50 JlM) and 
methoxytryptamine (50 JlM) ori production of tumor 
ne~rosis factor-a (= inhibtion of L929 growth) by 
peritoneal macrophages from C57 mice. The tumor 
necrosis factor-a - containing supematant was diluted 
200 folds for assay. Results are expressed as means + 
standard deviation (n = 3). VEH = control, MEL = 
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Figure 3.11 In vitro 'production of tumor . necrosis factor-a (= 
inhibition of L929 growth) by peritoneal macrophages 
from C57 mice (N . 20/group) which had been treated 
with melatonin or methoxytryptamine in the drinking 
water (100 J.lg/ml) for 2 weeks. The tumor necrosis 
factor-a containing supematant was diluted 200 folds 
before assay. . Results are expressed as means + 
standard deviation (n = 3). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 
control. VEH. = control, MEL = melatonin, MT A = 
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Figure 3.12 In vitro production of turnor necrosis' factor-(x ( . 
inhibition of L929 growth) by peritoneal macrophages 
from C57 mice (N = 20/group) which had been treated 
with melatonin or methoxytryptamine in the drinking 
water (100 Jlg/ml) for 2. weeks. The turnor necrosis 
factor-a containing supematant was diluted 400 folds 
before assay. Results · are expressed as means + 
standard deviation. (n = 3). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 
. -control. A cross (+) denotes a statistically significant 
difference (p < 0.05) from corresponding melatonin 
group. VEH · = c~ntrol, MEL =-melatonin, MT A = 
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Figure 3.13 In vitro production of tumor necrosis factor-a (= 
inhibition of L929 growth) by peritoneal macrophages 
f!om C57 mice (N = 20/group) which had been tre~ted 
with melatonin or methoxytryptamine in the drinking 
water (100 Ilg/ml) for 2 weeks. The tumor necrosis 
factor-a containing supematant was diluted 800 folds 
before assay. Results are expressed as means + 
standard deviation (n = 3). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 
control. VEH = control, MEL = melatonin, MT A = 
methoxytryptaffiine, LPS = lipopolysaccharide. 
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Figure 3.14 Autoradiographs of actin and TNF-a rnRNAs in 
macrophages from C57 mice (N = 20/group) which 
had been treated with melatonin or methoxytrypt~ine 
in the drinking water (100 Jlg/ml) for 2 weeks, after 
treatment with LPS for difference durations. The 
numbers represent duration of LPS 'treatment in 
minutes. VEH = control, MEL = melatonin, MT A = 
methoxytryptamine, LPS = lipo - polysaccharide, TNF 
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Figure 3.15 Ratio of TNF-a mRNA : actin, mRNA in peritoneal 
macrophages from C57 mice (N = 20/group), which 
had been treated with melatonin or methoxytryptamine 
in the drinking water (100 Jlg/ml) for 2 weeks, after 
treatment with LPS for difference durations. VEH = 
control, MEL = me.latonin, MT A = methoxytryptamine, . 
LPS = lipopolysaccharide, TNF = tumor necrosis 
factor. 
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Chapter 4 Activation of murine splenocytes by melatonin and 
methoxytryptamine 
4.1 Introduction 
Pawlikowski (1988) reported that melatonin at concentrations of 10-4 - 10-8 M exerted 
- -
no significant influence on 3H-thymidine incorporation by spleen lymphocytes. Arzt 
(1988) found that only at a concentration in the range of 10-3 - 10-4 M did melatonin 
inhibit optimally stimulated proliferation of human peripheral blood T lymphocytes 
by phytohemagglutinin~ However, suboptimally stimulated proliferation of hqinan 
peripheral blood T lymphocytes by phytohemagglutinin was inhibited by melatonin 
at a concentration in the range of 10-3 - 10-7 M. 
Maestroni and his colleagues from the Institute for Integrative Biomedical Research 
in Switzerland have published three papers on role of the pineal gland in immunity. 
Maestroni (1986) found that melatonin injected into rmce was able to antagonize the 
depression of antibody production by corticosterone in vivo and reverse the 
suppressIon of humoral response and autologous mixeq. lymphocyte reaction by 
propranolol and p-chlorophenylalanine. Propranolol is a B-antagonist which 
antagonizes the action of norepinephrine on the no'cturnal rise in pineal hormone 
production. p-Chlorophenylalanine was able to deplete serotonin in the central 
nervous system (Sanders 1974). Serotonin is the precursor and limiting substrate of 
melatonin. Maestroni (1986) found that the opioid receptor blocker, naltrexone, was 
able to antagonize the enhancing effect of melatonin on primary antibody response 
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In VIVO. He suggested that melatonin enhanced the antibody response VIa an 
opiatergic mechanism. Maestroni (1988) found that naltrexone' was also able to 
antagonize the counteracting effect of melatonin on immunosuppression induced by 
acute stress. Injection of melatonin in the evening was also found to prevent 
paralysis and death of mice induced by sublethal doses of encephalomyocarditis virus 
after acute stress (Maestroni 1988). Maestroni (Giorda 1991) published another paper 
on . melatonin - induced enhancement of antibody - dependent cellular cytotoxicity. 
Administration of melatonin into mice was able to enhance the antibody - dependent 
cellular cytotoxicity of leukocyte effector cells. The enhancement was not inhibited _ 
by the opioid antagonist, naloxone. 
Investigations about 'immunomodulatory effect of pineal indoles concentrated on 
serotonin and melatonin were few in number and mostly confined to study on 
lymphocytes. Since melatonin was found to have stimulatory effects on macrophages 
only in. vivo, it was suspected that the indole could also affect the cytokine activity 
in vivo. Methoxytryptamine, which was not cytotoxic to macrophages, was found to 
have some stimulatory effect on certain functions of macrophages in vivo. Both 
indoles were thus studied in this investigation. 
4.2 Materials and methods 
4.2.1 Chemicals 
Melatonin (MEL) , methoxytryptamine (MT A), lipopolysaccharide (LPS) from 
82 
Escherichia coli, Concanavalin A were obtained from Sigma Chemical Co. Stocks 
of melatonin and methoxytryptamine were prepared by dissolving 50 mg pineal 
indole in 2 ml 95% alcohol. 
4.2.2 Culture media 
Dulbecco's modified Eagle's medium without phenol red (catalog no. D 2902), 
Dulbecco's phosphate buffered saline (catalog no. 0 5652), Hank's balanced salts 
(catalog no. H 2387) and RPMI-1640 (catalog no. R 65.04) were purchased from 
Sigma Co. Generally" they were first unpacked and dissolved in 800 ml ·· .fresh 
double-distilled water. They were stirred gently for 3 - 4 hours. 2 g sodium 
bicarbonate was then \ added into RPMI, 3.7 g sodium bicarbonate was added into 
Dulbecco's modified Eagle's medium and 0.35 g sodium bicarbonate was added into 
Hank's balanced salt solution. 0.1 g MgC12-6 H20 and 0.133 g CaC12-2 H20 were 
added into Dulbecco's phosphate-buffered saline. The solution was stirred for a few 
minutes. The pH of the s·olution was adjusted to 7.2 while stirring. Then the 
solution was adjusted to 1'L with fresh double-distilled water. Finally, the medium 
was sterilized by filtration using sterile 0.22 Jlm millipore filter. The sterile medium 
was then transferred . to a sterile container for storage. RPM! and Dulbecco' s 
modified Eagle's medium were supplemented with 10 % fetal bovine serum, 
streptomycin sulfate (100 Jlg/ml) and penicillin G (100 IU/ml). 
4.2.3 Animals 
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Escherichia coli, Concanavalin A were obtained from Sigma Chemical Co. Stocks 
of melatonin and methoxytryptamine were prepared by dissolving 50 mg pineal 
indole in 2 ml 95% alcohol. 
4.2.2 Culture media 
Dulbecco's modified Eagle's medium without phenol red (catalog no. D 2902), 
Dulbecco's phosphate buffered saline (catalog no. D 5652), Hank's balanced 'salts 
(catalog no. H 2387) and RPMI-1640 (catalog no. R 6504) were purchased from 
Sigma Co. Generally; they were first unpacked and dissolved in . 800ml :fresh 
double-distilled water. They were stirred gently for 3 - 4 hours. 2 g -sodium 
bicarbonate was then' added into RPMI, 3.7 g sodium bicarbonate was added into 
Dulbecco's modified Eagle's medium and 0.35 g sodium bicarbonate was added into 
Hank's balanced salt solution. 0.1 g MgC12-6 H20 and 0.133 g-CaCI2-2 -H20 were 
added into Dulbecco' s phosphate-buffered saline. The solution was stirred for a few 
minutes. The pH of the solution was adjusted to 7.2 while stirring. Then the 
solution was adjusted to l' L with fresh double-distilled water. Finally, the medium 
was sterilized by filtration using sterile 0.22 flm millipore filter. · The sterile medium 
was then transferred _ to- a sterile container for storage. RPMI and Dulbecco' s 
modified Eagle's medium were supplemented with 10 % fetal bovine serum, 
streptomycin sulfate (100 J.lg/ml) and penicillin G (100 IU/ml). 
4.2.3 Animals 
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Inbred male C5? BL/6 mice, 8-12" weeks old, were used in this study. One group 
was provided with 2 ml melatonin solution (25 mg/ml in 95 % ethanol) in 500 ml 
drinking water, another group with 2 ml methoxytryptamine solution (25 mg/ml in 
95 % ethanol) in . 500 ml drinking water, while the third group received 2 ml 95 % 
alcohol in 500 ml drinking ~ater and served as the control. The animals were kept 
a! 21 + 2 QC under a 14/10 - light/dark cycle so that the animals were physiologically 
pinealectomized. The animals were maintained on standard rodent chow. 
4.2.4 Preparation of splenocytes for assay 
Animals were killed by cervical dislocation ~nd spleens were aseptically excised from 
C5? mice and transferred to Hank's Balanced Salt Solution. They were then cut into 
small pieces and pressed through a 100 - mesh stainless steel sieve aseptically. The 
cells in the medium were spun down and w-ashed with Hank's Balanced Salt Solution. 
They were counted and resuspended at 1 X 107 cells/m! RPMI medium. 
4.2.5 Preparation of peritoneal macrophages for assay 
3 % thioglycolate solution, which was sterilized and aged for at least 1 month, was 
. . . 
injected into control C5? mice to elicit macrophages towards the peritoneal cavity for 
3 days. The . thioglycolate-elicited peritoneal macrophages were collected by 
peritoneal lavage with Hanks' balanced salt solution (Liu et al. 1989). The 
macrophages were resuspended in RPMI 1640 at a concentration of 2 x 106 cells/ml. 
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4.2.6 Preparation of crude lymphokines for assay 
15 ml of spleen cells (1 X 107 cells/ml) were cultured in a 75 cm2 culture flask 
(Sterlin) in RPMI medium which contained 10 ~g/m1 Concanavalin A (CON ,A) for 
3 hours. The culture medium was decanted and the monolayer of lymphocytes was 
rinsed carefully with warm phosphate -' buffered saline to remove exces~ CON A. 
The cells were incubated for an additional 24 hours at 37 QC with 15 ml fresh . 
supplemented RPMI (for the assay of macrophage activating factor) or DMEM 
without phenol red (for the assay of nitrite). After 24 hours the cell-free supernatant 
containing crude lymphokines was collected and sterilized by passing through a:O.22 
~m millipore filter. It was stored at -70 QC. 
4.2.7 Preparation of scintillation fluid 
0.4 g POPOP and 4 g PPO were dissolved in 700 ml toluene and mixed for 3 hours. 
300 ml Triton X-lOO was then added to the mixture to bring the volume to -1 L. 
4.2.8 Assay of mitogenic response of splenocytes 
Mitogenic response was detennined by incubating 1 X 106 splenocytes /0.1' mlIwell 
with an equal volume of different dilutions of CON A ' or LPS in 96-well flat -
bottom microtest plates (Sterlin) at 37 QC in a humidified atmosphere of 5 % CO2, 
. The cultures were incubated for 48 hours. During the last 6 hours, the cells were 
pulsed with 0.5 ~Ci of methyl-3H-thymidine /10 ~l /well. Cells were harvested onto 
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a glass fib er filter paper. Each well of cells was mixed with 1 ml scintillation fluid 
in a counting vial. The radioactivity was measured using a Beckman scintillation 
counter. The mitoge~ic response was expressed as the stimulation index, which was 
the ratio of uptak~ of 3H-thymidine by splenocytes treated with CON A to uptake of 
3H-thymidine by control splenocytes cultured in medium. The lack of an adverse 
effect 9f pineal indoles on viability of splenocytes was established by the trypan blue 
exclusion test. 
4.2.9 Assay of ,,(-interferon pr.oduction by splenocytes 
Crude lymphokines were used to test for the concentration of ,,(-interferon. U sing an 
InterTest-yTM Mouse 'lFN-"( ELISA Test Kit from Genzyme Corporation (Genzyme 
catalog no. 1557-00). 
4.2.9.1, Coating plate with capture reagent (first antibody) 
38 Jll of monoclonal anti-mIFN-'y (Genzyme catalog no. 1547-01) was diluted into 
11 ml coating buffer (Genzyme catalog no. 1168-00). Diluted monoclonal antibody 
(100 Jll) was added tq each well of the 96 - well plate. The plate was then incubated 
overnight at 4 cC. 
4.2.9.2 /Preparation of assay solutions 
The washing buffer was prepared by reconstituting the PBS powder (Genzyme 
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catalog no. 1175-00) in 2 liters of distilled water containing 1 ml of surfactant 
(Genzyme catalog no. 1167-00). Blocking/dilution buffer was prepared by adding 15 
ml of concentrated blocker/diluent (Genzyme catalog no. 1463-00) to 60 ml Washing 
Buffer. 2 N sulf~c acid was prepared by diluting concentrated sulfuric acid 5 - fold 
with distilled water. 
4.2.9.3 Blocking the plate 
The coating mixture in the plate was decanted. The. plate was washed with washing . 
buffer and dried. 200' JlI blocking/dilution buffer was added into each well. ';~ '- The 
plate was incubated at 37°C for 30 minutes. 
4.2.9.4 Incubation of StaMorrd aruil Sample 
Differe,nt dilutions of standard (Genzyme catalog no 1549-00) were prepared. The 
blocking buffer in the plate was decanted and the plate was dried. The standard and 
the samples were added into the plate. The plate was then incubated at room 
temperature for 2 hours. 
4.2.9.5 ,Addition of Second Antibody 
The solution in the plate was decanted and the plate was washed with washing buffer 
four times. 440 JlI of goat anti-IFN-:-y (Genzyme catalog no. 1548-00) was diluted 
into 10.5 ml blocking/dilution buffer. 100 JlI of diluted secondary antibody was 
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added into each well of the plate. The plate was incubated at room temperature for 
2 · hours. 
4.2.9.6 Addition of Third Antibody 
The solution in the plate was decanted. ' The plate was washed with washing buffer 
four times and dried. 11 JlI of peroxidase - conjugated donkey anti - goat (Genzyme 
catalog no. 1465-00) antiserum was diluted into 11 ml blocking/dilution buffer.' 100 
JlI of diluted third antibody was added into each well of the plates. The plate was 
then incubated. at room temp~rature for one hour. 
4.2.9.7 Addition of SiIJ,bstr'ate and stopping color 'development 
50 JlI of peroxide solution was diluted in 11 ml substrate buffer (Genzyme catalog 
no. 1171-00). 2 OPD (O-phenylenediamine dihydrochloride) tablets (Genzyme 
catalog no. 1508-01) were ' added into the substrate buffer/peroxide solution and 
mixed gently to dissolve. The resulting solution was the substrate reagent. The 
solution in the plate was decanted. The plate was washed with washing buffer four 
times and dried.. 100, Jll- of substrate reagent was added into each well of the plate. 
The reaction was leff to develop for 4 - 6 minutes at room temperature. 100 JlI o.f 
2 N sulfuric acid was added into each well of the plate to stop color development. 
Absorbance at 490 nm was then read to measure the level of IFN-y in the tested 
. crude lymphokines. 
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4.2.10 Assay of interleukin - 2 production by splenocytes 
It was detennined according to the method described by Gillis (1978). Different 
dilutions ' of interleukin - 2 standard from Genzyme (code MIL-2) were used to 
stimulate the growth of CT~L 2 cells (mouse T cells from ATCC, catalog no. TIB 
2-14). 2 X 104 CTLL 2 cells/50 Jll/weli were seeded into a 96 - well plate. 50 JlI of 
different dilutions of the standard or samples was added into the plate. The plate was 
incubated at 37 QC in a humidified atmosphere of 5 % CO2• The cultures ' were 
incubated for 48 hours. During .the last 6 hours, the cells were pulsed with 0.5 JlCi 
of methyl-3H-thymidin~ (Amersham)/10 Jll/well. Afterwards the cells were harvested 
onto a glass fiber filter paper. Each well of cells was mixed with 1 ml scintillation 
fluid in a counting vial. The 'radioactivity 'was measured using ' a Beckman 
scintillation counter and the concentration of interleukin - 2 was expressed as U/ml. ' 
4.2.11 . Assay of nitrite production by macrophages after stimulation by 
lymphokines 
Thioglycolate - elicite4 peritoneal macrophages were collected and washed with 
Hanks' balanced salt solution. They were resuspended at a concentration of 2 X 106 
cells/ml supple~entea DMEM without phenol red. The cells (2 X 105/0.1 ml/well) 
were allowed to adhere onto the surface of the 96 - well culture plate for 2 hours 
before they were challenged with crude lymphokines (containing 10 ng LPS /ml) 
from different groups of mice for 1 day. The supematant was then allowed to react 
with half its volume of Griess reagent (1 % sulfanilamide in 5 % H3P04 - 0.1 % 
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naphthalene-ethylenediamine dihydrochloride) for 15 minutes and the level of nitrite 
present in the culture medium was measured by an ELISA reader at 540 nm. The 
concentration of nitrite was estimated using NaN02 as the standard and expressed as 
JlM . 
. 4.2.12 Assay o/production o/macrophage activating/actor (MAF) by splenocytes 
Tumoricidal activity of MAF-activated macrophages was assayed with a modification 
of the method of Taramelli (1980). Serial dilutions (1:1) of a suspen"sion (2 X 106 
cells/m!) of thiog~ycohlte - elicited peritoneal macrophages were prepared. Different 
~ 
dilutions of peritoneal macrophages was seeded into a 96 - well plates. Crude 
) 
lymphokines containing 10 ng LPS /m! in 1 : 1 dilution were used to stimulate the 
peritoneal macrophages at 37°C for 24 hours. The peritoneal macrophages were 
then washed with warm phosphate - buffered saline two times. 100 JlI of murine 
mastocytoma P815 cells at a concentration of 5 X 104 cells/ml was then added into 
each well of the plate and incubated at 37 QC for 48 hours. During the last 6 hours, 
the cells were pulsed with 0.5 JlCi of methyl-3H-thymidine (Amersham) /10 JlVwell. 
The cells were then harvested on a glass fiber filter paper. Each well of cells was 
"mixed with 1 m! scintillation fluid in a counting vial. The radioactivity was 
measured using a Beckman scintillation counter. 
4.2.13 Statistics 
The data were analyzed by one - way analysis of variance using Scheffe'smultiple 
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range test. The levels of significance were taken at p < 0.05. 
4.3 Results 
4.3.1 Mitogenic response of mouse splenocytes to CON A. The mice had been 
treated with melatonin and methoxytryptamine in the drinking water for 2 
weeks. 
Splenocytes from mice treated with vehicle), melatonin, or methoxytryptamine in the 
drinking water were respectively cultured with different concentrations of CON·'A for 
48 hours. Their 3H-thymidine uptakes were then used to calculate the stimulation 
index. The stimulation index is the ratio of 3H-thymidine uptake of splenocytes 
cultured with CON A to 3H-thymidine uptake -of splenocytes cultured in medium. 
The result is shown in Figure 4.1. The mitogenic response to , CON A was the 
greatest in the melatonin - treated group (about 25 % higher than the control group 
when 10 J.lg CON A /ml was used). The mitogenic response of the 
methoxytryptamine - treated group to CON A was lower than the control group 
(about 20 % smaller than the control group when 10 J.lg CON A /ml was used). The 
differences were distinct when 10 J.lg CON A /ml was used. Smaller differences 
found at higher concentrations of CON A may have been due to overgro~th of the 
-splenocytes. 
4.3.2 Mitogenic response of mouse splenocytes to lipopolysaccharide (LPS). The 
mice had been treated with melatonin and methoxytryptamine in the 
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drinking water for 2 weeks 
Splenocytes from mice treated with the vehicle, melatonin, and methoxytryptamine 
respectively in the drinking water were cultured with different concentrationst of LPS 
for 48 hours. Their 3H-thyrriidine uptakes were then used to calculate the stimulation 
index. The stimulation index is the ratio of 3H-thymidine uptake of splenocytes 
cultured with LPS to 3H-thymidine uptake of splenocytes cultured in medium. The 
result is shown in Figure 4.2. The mitogenic response to LPS was the greatest in the 
melatonin - treated group (about 100 % higher than the control group when 4 ~g LPS 
/ml was used). The rriitogenic response of the methoxytryptamine - treated group to 
LPS was about 70 % higher than the control group when 4 ~g LPS /ml w-as used. 
The trends were similar at other concentrations ot LPS although the differences were 
smaller. 
4.3.3 In vitro production of y-interjeron by mouse splenocytes from mice which 
had been treated 'with melatonin and methoxytryptamine in the drinking 
water for 2 weeks 
Splenocytes from mice treated with vehicle, melatonin, and methoxytryptamine 
respectively in the dTInking water were pre - treated with 1 0 ~g CON A /ml for 3 
hours and cultured for 24 hours. The supematant was used to test for the activity of 
r 
'Y-interferon. . The standard curve of y-interferon was constructed according to the 
method described, in the . instructions accompanying the InterTest-iM Mouse IFN-y 
ELISA Test Kit and is shown in Figure 4.3. 8000 pg y-interferon standard /ml was 
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equivalent to about 36 units/ml. The result is shown in Figure 4.4. Splenocytes 
from melatonin - treated mice produced about 70 % more ·'Y-inteneron than 
-splenocytes from control mice significantly. Splenocytes from methoxytryptamine -
treated mice produced about 50 % more y-inteneron than splenocytes from tcontrol 
mice significantly. 
4.3.4 In vitro production of interleukin-2 by splenocytes from mice which had 
been treated with melatonin and methoxytryptamine in the drinking water 
for 2 weeks 
Splenocytes from tnlce treated with vehicle, melatonin, and methoxytryptamine 
respectively in the drinking water were pre - treated with 10 J..Lg CON A /ml for 3 
hours and cultured for 24 hours. The supematant was used to test the activity of 
. interleukin-2. The standard curve of interleukin-2 was constructed by using different 
dilutions of interleukin-2 from Genzyme to stimulate the growth of the CTLL 2 cells 
(Figure 4.5). The linear portion of the curve was then used for calculation (Figure 
4.6). The result is showri in Figure 4.7. Splenocytes from melatonin - treated rriice 
produced about 3 times as much interleukin-2 as splenocytes from control mice. 
Splenocytes from methoxytryptamine - treated mice produced about twice as much 
in terleukin-2 as splenocytes from control mice. 
4.3.5 In vitro nitrite production by peritoneal macrophages of mice after 
stimulation by crude lymphokines from mice which had been treated with 
melatonin and methoxytryptamine in the drinking water for 2 weeks 
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Splenocytes from mice treated with control, melatonin, and methoxytryptamine 
respectively in the drinking water were pre - treated with 10 Jlg CON A /ml for 3 
hours and cultured for 24 hours. The supematant was used to stimulate production 
of nitrite by peritoneal macrophages. The standard curve of nitrite 'was constructed 
by using sodium nitrite as ~tandard (Figure 4.8). The result .is shown in Figure 4.9 -
4.14. 
4.3.5.1 !In vitro nitrite produ.ction by peritoneal macropMges of control mice'after 
stimullation by crwile lymphokines from mic~ which had been treated with 
me llatonin and met!hoxytryptamine in the drinking water for 2 weeks (Figu.re 
4.9) 
Crude lymphokines from melatonin - treated .mice were able to stimulate peritoneal 
macrophages from control mice to-produce an about 40 % increase, in nitrite over that 
stimulated by crude lymphokines from control mice. Crude lymphokines from 
methoxytryptamine - treated mice were not able to stimulate peritoneal macrophages 
from control mice to produce an increase in nitrite-production over that stimulated 
by crude lymphokines-.from control mice. 
4.3.5.2. !In vitro nitrite production by peritoneaimacroplwiges o/melatonin - treated 
mice after stimulation by crude lympholdnes from mice which had been 
treated with me llatonin and methoxytryptamine in the drinking water for 2 
weeks (Figure 4.10) 
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Crude lymphokines from melatonin - treated mice were able to stimulate peritoneal 
macrophages from melatonin - treated mice to produce an about 8' - fold increase in 
nitrite production over that stimulated by crude lymphokines from control mice. 
Crude lymphokines from methoxytryptamine - treated mice were able to stimulate 
peritoneal macrophages fro.m melatonin - treated rrllce to produce an approximately 
4 - fold increase in nitrite production over that stimulated by crude lymphokines from 
control mice. 
4.3.5.3 In vitro nitrite production by peritoneal macro phages of met!hoxytryptamine 
- treated mice after stimulation, by crUlde lympholdnes from mice which hotd 
been treated with melatonin arull-methoxytryptamine in the drinking water 
for 2 weekS (Figure 4.11) 
Crude lymphokines from melatonin - treated mice were able to stimulate peritoneal 
macrophages from methoxytryptamine - treated mice to produce an approximately 5 -
fold increase in nitrite production over that stimulated by crude lymphokines from . 
control mice significantly. Crude lymphokines from methoxytryptamine - tre~ted 
mice were able to stimulate the peritoneal macrophages from methoxytryptamine -
treated mice to produce an approximately 3 - fold increase in nitrite production over , 
that stimulated by crude lymphokines from control mice. 
4.3.5.4 In vitro nitrite R.roduction by peritoneal nwtcrophages from mice which had 
been treated with melatonin and methoxytryptamine in the drinking water 
for 2 weeks. The macro phages had been subjected to in' vitro stimulation 
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by crude iymphokines from control mice (Figure 4.12). 
The response of peritoneal macrophages from methoxytryptamine - treated mice to 
crude lymphokin~s from control · mice in nitrite production was approximately 40 % 
higher than that produced by peritoneal macrophages from control mice. The 
response of peritoneal macrophages' from melatonin - treated mice to crude 
lymphokines from control mice was not significantly different when compared to that 
produced by peritoneal macrophages from control mice. 
4.3.5.5 In vitro nitrite production by peritoneall!rWJ.cropMges from mice which ·had, 
been treated with melatonin and methoxytryptamine in the drinking water 
for 2 weeks. The macropMges had been subjected to in vitro stimulation 
by cr7tM1le lymphoJdnes from melatonin - treated mice (Figure 4.13). 
The response of peritoneal macrophages from melatonin - treated mice to crude 
lymphokine from melatonin - treated mice in -nitrite production was about 30 % 
higher than that produced by peritoneal macrophages . from control mice. The 
response of peritoneal macrophages from methoxytryptamine - treated mice to crude 
lymphokines from m~latonin - treated mice was approximately 70 % higher than that 
produced by peritoneal macrophages from control mice. 
4.3.5.6 In vitro nitrite prodoction by. peritoneal rntlJcrophotges from mice treated 
with melatonin and methoxytryptamine in the drinking water for 2 weeks. 
The macro phages had been subjected to in vitro . stimulation by crude 
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lymphokines from methoiytryptamine - treated mice (Figure 4.14). 
The response of peritoneal macrophages from melatonin - treated mice to crude 
lymphokines from methoxytryptamine - treated mice in nitrite production was about 
50 % higher than that produced by peritoneal macrophages from control mice. The 
response of peritoneal macrophages from methoxytryptamine - treated mice to crude 
lymphokines from methoxytryptamine - treated mice was about 70 % higher than that 
produced by peritoneal macrophages from control mice. 
4.3.6 Production of macrophage activating factor by splenocytes after treatment 
with melatonin and methoxytryptamine 
The assay did not directly monitor the amount of macrophage activating factor. It 
was reflected by the ability of macrophages to kill murine mastocytoma P815 cells 
after stimulation. Splenocytes from mice treated with melatonin and 
methoxytryptamine respectively in the drinking water were pre - treated with 10 Ilg 
CON A /ml for 3 hours and cultured for 24 hours. 1/2 Dilution of the supernatant 
containing crude lymphokines was then used to stimulate the peritoneal macrophages. 
The inhibition of the growth of murine mastocytoma P815 cells was calculated from 
3H-thymidine uptake· of murine mastocytoma P815 cells. The result is shown in 
Figure 4.15 - 4.20. 
4.3.6.1 In vitro killing of murine mastocytoma JP815 cells by peritoneal 
macro phages of mice which had been treated with melatonin or 
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methoxytryptamine in tlui' drinking water for 2 weeks. The JmOJcrophages 
Md been subjected to in vitro stimulation by crude lympholdnes from 
control mice (Figure 4.15). 
Crude lymphokines from control mice were able to activate peritoneal macrophages 
~rom control mice to produce about '35 % inhibition of the growth of murine 
mastocytoma P815 cells. There was no significant difference in the response of 
peritoneal macrophages from different groups of mice to activation by crude 
lymphokines from control mice. 
4.3.6.2 In vitro killing of murine 1fIWJstocytoma !PSiS ceUs by peritoneal 
rrwJcrophages of mice which had been treated with melatonin or 
methoxytryptamine in the drinking water for 2 weeks. The l!7!Wlcrophages 
Md been subjected to in vitro stimulation by crude lympholdnes from 
mel1atonin - treated mice (Figure 4.16). 
Crude lymphokines from melatonin - treated mice were able to activate peritoneal 
macrophages from melatonin - treated mice to produce about 90 %. inhibition of the 
growth of murine mastocytoma P815 cells, which was about 35 % higher than that 
achieved by macrophages from control mice when the ratio of the number of 
macrophages to the number of murine mastocytoma P815 cells was 40 to 1. Crude 
lymphokines from melatonin - treated mice were able to activate peritoneal 
macrophages from methoxytryptamine - treated mice to produce 98 % inhibition of 
the growth of murine mastocytoma P815 cells, which was about 50 .% higher than 
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that achieved by macrophages from control mice when the ratio of the number of 
macrophages to the number of murine mastocytoma P815 cells was 40 to 1. 
4.3.6.3 In vitro killing of murine mastocytoma lP815 cells by peritoneal 
mtJJcrophatges of -mice which had been treated with melatonin or 
methoxytryptamine in. the drinking water for 2 weeks. The matcrophages 
had been subjected to in vitro stimulation by crUMile lymphokines from 
metlhoxytryptamine - treated mice (Figure 4.17). 
Crude lymphokines from methoxytryptamine - treated mice were able to activate 
~ 
peritoneal macrophages from control mice to produce about 35 % inhibition of the 
growth of murine mastocytoma P8I5 cells. There was no significant difference in 
the response of peritoneal macrophages from different groups of mice to activation 
by crude lymphokines of mice from methoxytryptamine - treated mice. 
4.3.6.4 In vitro killing of murine mastocytoma lP815 cells by peritoneal 
. . 
matcroplhtJJges of control mice after in vitro stimulfation by crwJ1e lymphokines 
from melatonin - treated or methoxytryptamine - treated mice (Figure 4.18) 
. ' 
Crude lymphokines from melatonin - treated mice were able to produce about 70 % 
inhibition of the growth of murine mastocytoma P8I5 cells by macrophages from 
control mice, which was about 1 - fold higher than that stimulated by crude 
lymphokines from control mice when the ratio of the number of macrophages to 
murine mastocytoma P815 cells was 40 to 1. The activity of macrophage activating 
99 
factor in the crude lymphokines from methoxytryptamine - treated mice was not 
significantly different from that in the crude lymphokines from control mice. 
4.3.6.5 In vitro kiUing of murine JmOJstocytoma lP815 · cells by peritoneal" 
macro phages from melatonin - treated mice after in vitro stimulation by 
crP.Mile lymphol/dnes from melatonin - treated or methoxytrryptamine - tJreated 
mice (Figure 4J. .19 ) 
When the ratio of the number of macrophages to the number of murine mastocytoma 
P8I5 cells was 40 to 1, crude lymphokines from melatonin - treated mice were'-able 
to produce about 90 % inhibition of the growth of murine mastocytoma P8I5 cells 
by macrophages from melatonin - treated mice, ·which was about 3.5 - fold higher 
than that stimulated by crude lymphokines from control mice. When the ratio of the 
number of macrophages to the number of murine mastocytoma P815 cells was 20 to 
1, crude lymphokines from melatonin - treated mice were able to stimulate about 40 
% inhibition of the growth 6f murine mastocytoma P815 cells by .macrophages from 
melatonin - treated mice, which was about 1 - fold higher than that stimulated by 
crude lymphokines from control mice. The activity of macrophage activating factor 
. in the crude lymphokines from methoxytryptamine - treated mice was not 
significantly different when compared to the crude lymphokine from control mice. 
4.3.6.6 In vitJro killing of murine mastocytoma lP815 cells by peritoneal 
lJ1WJcrophages from methoxytryptamine - treated mice after in vitro 
stimullation . by crP.Mi1e lymphokines from melatonin - treated or 
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methoxytryptamine - treated mice (Figure 4.20) 
When the ratio of the number of macrophages to the number of murine mastocytoma 
P815 cells was 40 to 1, crude lymphokines from melatonin - treated mice were able 
to produce about 98 % irihi:hition of the growth of murine mastocytoma P815 cells 
by macrophages from methoxytryptamine - treated mice, which was about 2.3 - fold 
higher than that stimulated by crude lymphokine from control mice. When the ratio 
of the number of macrophages to murine mastocytoma P815 cells was 20 to 1, crude 
lymphokines from melatonin - treated mice were able to produce about 40 % 
inhibition of the growth of murine mastocytoma P815 cells by macrophage~,,~from 
methoxytryptamine - treated mice, which was about 1 - fold higher than that 
stimulated by crude lymphokines from control mice. The activity of macrophage 
activating factor in the crude lymphokines from methoxytryptamine - treated mice 
was not significantly different when compared to crude lymphokines from control 
mice, when the ratio of the number of macrophages to the number of murine 
mastocytoma P815 cells was 20 to 1. The activity of macrophage activating factor 
in the crude lymphokines from methoxytryptamine - treated mice 'was shown to· be 
about 50 % lower than that of control mice when thy ratio of the number of 
macrophages to the ~umber of murine mastocytoma P815 cells was 40 to 1. 
4.4 Discussion 
Several conclusions about melatonin can be drawn from the results. Firstly, 
splenocytes from melatonin - treated mice exhibited greater mitogenic responses to 
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CON A (25 %) and LPS (100 %) than splenocytes from control mice. Splenocytes 
from methoxytryptamine - treated mice manifested a lower mitogenic response to 
CON A (20 %) and a greater mitogenic response to LPS (70 %) than splenocytes 
from control mice. 
Secondly, splenocytes from both melatonin - treated and methoxytryptamine - treated 
mice produced more y-interferon and interleukin-2 than splenocytes from control 
mIce. In this regard melatonin had a greater stimulatory effect than 
methoxytryptamine in the production of y-interferon and interleukin--2. 
Thirdly, when the effects of various crude lymphokines obtained for different groups 
of mice on a given type of macrophages were investigated, it was found that crude 
lymphokines from splenocytes of melatonin - treated and methoxytryptamine - treated 
mice were able to stimulate nitrite production by macrophages (from control mice, 
melatonin - treated mice, as well as from methoxytryptamine ~ treated mice) to a 
greater extent than crude lyinphokines from splenocytes of control mice, suggesting 
that macrophage activating factor was present- at higher concentrations in preparations 
of crude lymphokines from splenocytes of melatonin - treated and methoxytryptamine 
- treated mice than crude lymphokines from control'mice. Crude lymphokines from . 
melatonin-treated mice had a greater stimulatory effect on macrophage nitrite 
production than those from methoxytryptamine-treated mice, implying that the former 
contained a higher concentration of macrophage activating factor. It appeared that 
melatonin exerted a greater stimulatory effect on lymphocytes than 
methoxytryptamine . . 
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Fourthly, when the effect of a 'given crude lymphokines was- tested-'on macrophages 
from different group of mice, it was found that macrophages from melatonin - treated 
mice produced more nitrite than macrophages from control mice when they were 
activated by crude lymphokines from melatonin - treated mice or methoxytryptamine 
- treated mice. ' Macrophages frommethoxytryptamine - treated mice produced the 
highest nitrite level when compared to macrophages from control mice and melatonin 
- 'treated mice, when they were activated by crude lymphokines from control mice, 
melatonin - treated nnce, and methoxytryptamine - treated mice. The data suggest 
that macrophages from melatonin - treated ' and methoxytryptamine - treated mice 
were more sensitive tc? the action of lymphokines than macrophages from control 
mice and that methoxytryptamine treatment rendered the macrophages more sensitive 
to the action of lymphokines than m~latonin treatment. 
Fifthly, crude lymphokines from melatonin - treated nnce but not those from 
methoxytryptamine - treated mice were able to stimulate greater inhibition of the 
growth of murine mastocyt~ma P815 cells by macrophages from control mice (1 -
fold), melatonin - treated mice (2.5 - fold) and methoxytryptamine - treated mice (1.3 
- fold) when compared to crude lymphokines from control mice, indicating that 
macrophage activating factor was present at a higher concentration in crude 
lymphokines from I?elatonin - treated mice. The same was not true of crude 
lymphokines fronl methoxytryptamine - treated mice. This finding again suggests 
that melatonin exerts a stronger stimulat?ry effect on lymphocytes than 
methoxytryptamine. 
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Sixthly, macrophages from both melatonin - treated and methoxytryptamine - treated 
mice elicited greater inhibition of the growth of murine mastocytoma P8I5 cells than 
macrophages from control mice when they were stimulated by crude lymphokines 
from melatonin - ·treated mice, suggesting that macrophages from melatonin';: treated 
and methoxytryptamine - treated mice were more sensitive than macrophages from 
control mice to crude lymphokines from melatonin - treated mice. Again the higher 
response observed in macrophage for methoxytryptamine-treated mice suggests that 
methoxytryptamine exerts a stronger stimulatory effect on macrophages than 
melatonin. The lack of' differential respon~es among macrophages of the various 
groups of mice t? crude lymphokines from control mice and methoxytryptatiiine -
treated mice may be attributed to the lower activity of macrophage activating factor 
in these lymphokine' preparations. 
In summary, treatment with melatonin or methoxytryptamine induced the splenocytes 
to secrete a higher level of interleukin-2 and y-interferon which then act on the 
peritoneal macrophages. The macrophages then respond by secreting nitrite which 
exerts a killing effect on tumor cells. Melatonin and methoxytryptamine may also 
act directly on the macrophages to sensitize them to the action of interleukin-2 and 
y-in terferon. 
CON A is known as a T cell mitogen while LPS is known as a B cell mitogen. 
\ 
Splenocytes from melatonin - treated mice showed a greater mitogenic response in 
both T cell and B cell populations when compared to splenocytes from control mice. 
Splenocytes from methoxytryptamine - treated mice showed a lower but not 
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significant different mitogenic response in T cell population and a higher mitogenic 
response in B cell populations when compared to splenocytes from control mice. It 
was important to the animals since the spleen is an important lymphoid organ. 
Lymphocytes with a greater response to stimulants are expected to acquire higher cell 
- mediated and humoral - immune response. It was further proved by the fact that 
splenocytes from melatonin - treated mIce produced more y-interferon and interleukin 
- 2 than splenocytes from control mice. Splenocytes from methoxytryptamine -
treated mice exerted a smaller enhancing effect in the same parameters ' when 
compared to splenocytes from melatonin - treated mice. However, the lack of a 
. . 
stimulatory effect of methoxytryptamine on the mitogenic response to ' CON'- A is 
enigmatic. 
Interferons are proteins (Friedman 1981) that induce an antiviral state in animal cells 
and also other biological activities. y - interferon is . secreted mainly by T 
lymphocytes. It stimulates macrophages and natural killer cells. It first inhibits and 
later enhances antibody formation by B lymphocytes. Mixed lymphocytes culture is 
a measure of function T lymphocytes. y - interferon is known to decrease the mixed 
lymphocytes reaction, which may be due to the negative feedback mechanism of the 
cytokine. The augmented generation. of y-interferon following melatonin and 
methoxytryptamine treatment points to an immunostimulatory action of the pineal 
indoles. 
Interleukin - 2 is also known as a. T cell growth factor, which is widely used to 
maintain the growth of the murine tumor - specific cytotoxic T cell lines (Gillis 
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1978). Cytotoxic T cells are important effector cells other than macrophages which 
maintain the cell - mediated immune response of the immune system. Besides, pre-
culture with interleukin - 2 enhanced the cytotoxic activity of peripheral blood or 
spleen cell populations. The activated cells are termed lymphokine activated killer 
cells. Their pre~ursor cells' are indistinguishable from natural killer cells so they may 
not represent separate cell lineage. Interleukin - 2 has also been reported (Strieter 
1989) to induce tumor necrosis factor - a gene expression in human alveolar 
macrophages and blood monocytes. Lewinski (1989) reported that melatonin 
suppressed natural killer cells in vitro. Results of the present study are at variance 
with his finding bec'ause melatonin and methoxytryptamine treatments resulted in 
elevated production of interleukin-2 by splenocytes. 
However, it was surprisirig that macrophages from methoxytryptamine - treated mice 
exhibited a greater response to stimulation than macrophages from. melatonin - treated 
tnlce. Actually, one of the macrophage activating factors is y-interferon. 
Macrophage activation is known to require the action of y-interferon. Taramelli 
(1981) found that LPS was absolutely required for macrophage activation in the 
murine mastocytoma P8~5 microcytotoxicity test. Ding (1988) tested the ability of 
twelve different cytokines including a - interferon, p- interferon, y - interferon, TNF 
- a, TNF - p, CSF "- ·GM, CSF - M, interleukin - 1 p, interleukin - 2, interleukin - 3, 
interleukin - 4, and TGF - P to induce nitrite and hydrogen peroxide production by 
macrophages. He found that y - interferon was the only cytokine capable of inducing 
both nitrite and hydrogen peroxide .release. He also found that the arginine analog, 
W -monomethylarginine, inhibited nitrite release but . not hydrogen peroxide 
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production. Nitrite is important for macrophages to carry out its cytotoxic functions. 
L - arginine is required for expression of the activated macrophage effector 
mechanism causing selective metabolic inhibition in target cells (Hibbs 1987). These 
metabolic changes include inhibition of mitochondrial respiration such as activities 
of NADH : ubiquinone o~idoreductase and succinate : ubiquinone oxidoreductase, 
inhibition of aconitase in citric acid cycle, and inhibition of incorporation of 3H_ 
thymidine into the DNA. Nitrate and nitrite, also known as reactive nitrogen 
intermediates, are the metabolites of the L - arginine (Hibbs 1987). Inhibition 'of the 
growth of murine mastocytoma P815 cells was the result of an action of the reactive 
nitrogen intermediates produced by the peritoneal macrophages after stimtllation by 
macrophage activating factor (e.g. y-interferon) secreted by the splenocytes. The 
present study revealed a disparity in the immunoregulatory actions of melatonin and 
methoxytryptamine although similarities do exist. Differences were observed in the 
mitogenic response-to CON A and in the activity of macrophage activating factor 
secreted by the splenocytes. The similarities in action point to an immunostimulatory 
role of the two pineal indoles but it appears that melatonin exerts a stronger 
stimulatory effect on lymphocytes whilemethoxytryptamine exerts a stronger 
stimulatory effect on macrophages. It is noteworthy that differences between the 
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Figure 4.1 Mitogenic response of mouse splenocytes to CON A. 
The mice (N = 20/group) had been treated with 
ll.1elatonin and methoxytryptamine in the drinking water 
(100 J.1,g/ml) for 2 weeks. Results are expressed as 
means + standard deviation (n = 3). An asterisk (*) 
denotes a statistically significant difference (p < 0.05) 
from control. A cross (+ ) denotes a statistically 
significant difference (p < 0.05) from corresponding 
melatonin group. VEH = control, MEL = melatonin, 
MT A = methoxytryptamine, CON A = concanavalin A. 
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Figure 4.2 Mitogenic response of mouse splenocytes to LPS. The 
mice (N = 20/group) had been treated with melatonin 
and methoxytryptamine in drinking water (100 I-Lg/ml) 
for 2 weeks. Results are expressed as means + 
standard deviation (n = 3). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 
control. A cross (+) denotes a statistically significant 
difference (p < 0.05) from corresponding melatonin 
group. VEH = control, MEL = melatonin, MT A = 
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Figure 4.4 In vitro production of ",{-interferon by mouse 
splenocytes from mice (N = 20/group) which had been 
treated with melatonin and methoxytryptamine in the 
drinking water (100 J.!g/ml) for 2 weeks. Results ·are 
expressed as means + standard deviation (n = 2). An 
asterisk (*) denotes a statistically significant difference 
(p < 0.05) from control. A cross ( +) denotes a 
statistically significant difference (p < 0.05) from 
melatonin group. VEH = control, MEL = melatonin, 







1.6 25.6 409.6 6553.6 
Dilutions (x 103) of Re co mbinant IL-2 Standard 
Figure 4.5 Standard curve for recombinan,t interleukin-2 (IL-2) 
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Figure 4.6 Linear portion of standard cl!rve for recombinant 
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Figure 4.7 In vitro production of interleukin-2 . by . splenocytes 
from mice (N = 20/group) which had been· treated with 
melatonin and methoxytryptamine in drinking water 
(100 Ilg/ml) for 2 weeks. Results are expressed as 
means + standard deviation (n = 3). An asterisk (*) 
denotes a statistically significan~ difference (p < 0.05) 
from control. A cross (+) denotes a statistically 
significant difference (p < 0.05) from melatonin group. 
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Figure 4.9 In vitro nitrite production by peritoneal macrophages 
of control mice (N = 20/group) after stimulation by 
crude lymphokines from mice (N = 20/group) which 
had been treated with melatonin . and 
Ihethoxytryptamine in the drinking water (100 Jlg/ml) 
for 2 weeks. Results are expressed as means + 
standard deviation (n = 4). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 
control. A cross (+) denotes a statistically significant 
difference (p < 0.05) from melatonin group. VEH = 



















VEH MEL ' MTA 
Figure 4.10 In vitro nitrite production by peritoneal macrophages 
of melatonin - treated mice (N = 20/group) after 
stimulation by crude lymphokines from mice (N = 
20/group) which had been treated with melatonin and 
ITlethoxytryptamine in the drinking water (100 Jlg/ml) 
for 2 weeks. · Results are expressed as means + 
standard deviation (n = 4). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 
control. A cross (+) denotes a statistically significant 
difference (p < ·0.05) from melatonin group. VEH = 
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Figure 4.11 In vitro nitrite production by peritoneal macrophages 
of methoxytryptamine - treated'mice (N = 20/group) 
after stimulation by crude lymphokines from mice (N 
= 20/group) which had been treated with melatonin and 
methoxytryptamine in the drinking water (lOO 'Jig/ml) 
for 2 weeks. Results are expressed as means + 
standard deviation (n = 4). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 
control. A cross (+) denotes a statistically significant 
difference (p < 0.05) from melatonin group. VEH = 
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Figure 4.12 · In vitro nitrite production by peritoneal macrophages 
from mice (N = 20/group) which had been treated with 
melatonin and methoxytryptamine in the drinking water 
(100 J..Lg/ml) for 2 weeks. The macrophages had been 
subjected to in vitro stimulation by crude lymphokines 
from control mice (N = 20/group). Results are 
) expressed as means + standard deviation (n = 4). An 
asterisk (*) denotes a statistically significant difference 
(p < 0.05) from control. A cross (+ ) denotes a 
statistically significant difference (p < 0.05) from 
melatonin group. VEH = control, MEL = melatonin, 
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Figure 4.13 In 'vitro nitrite production by p~ritoneal macrophages 
from mice (N = 20/group) which had been treated with 
~elatonin and methoxytryptamine in the drinking water 
(100 Jig/ml) for 2 weeks. The macrophages had been 
subjected to in vitro stimulation by crude lymphokines 
from melatonin - treated mice (N = 20/group). Results 
are expressed as means + standard deviation (n = 4). 
An asterisk (*) denotes a statistically significant 
difference (p ' < 0.05) from control. A cross , (+) 
denotes a statistically significant difference (p < 0.05) 
from melatonin group. VEH =- control, MEL = 
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Figure 4.14 In vitro nitrite production by peritoneal rnacrophages 
from mice (N = 20/group) treated with melatonin and 
methoxy - tryptamine in the drinking water (100 
Jlg/ml) for 2 weeks. The macrophages had been . 
subjected to in vitro stimulation by crude lymphokines 
from methoxy - tryptamine - treated mice . (N = 
20/group). Results are expressed as means + standard 
deviation (n = 4). An asterisk (*) . denotes a 
. statistically significant difference (p < 0.05) from 
control. A cross (+) denotes a statistically significant 
difference (p < 0.05) from melatonin group. VEH = 


























Macrophages : P815 Cells 
Figure 4.15 In vitro killing of murine mastocytoma P815 cells by 
peritoneal macrophages of mice which have been 
treated with melatonin or methoxytryptamine in the 
drinking water for 2 weeks. The macrophages have 
been subjected to in vitro stimulation by crude 
lymphokines from control mice~ Results are expressed 
as means + standard deviation (n = 3). VEH = control, 
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Macrophages : P8I5 Cells 
Figure 4.16 In vitro killing of murine mastocytoma P8I5 cells by 
peritoneal macrophages of mice (N = 20/ group) treated 
'Yith melatonin or mehtoxytryptamine in the drinking 
water (100 Jlg/ml) for 2 weeks. The macrophages had 
been subjected to in vitro stimulation by crude 
lymphokines from melatonin ~ treated mice · (N = 
20/group). Results are expressed as means + standard 
- deviation (n == 3). An asterisk (*) denotes a 
statistically significant difference (p < 0.05) from 
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Macrophages : P815 Cells 
Figure 4.17 In vitro killing of murine mastocytoma P815 cells by 
peritoneal macrophages of mice (N = 20/ group) treated 
with melatonin or methoxytryptamine in the drinking 
water (100 Jlg/ml) for 2 weeks. The macrophages had 
been subjected to in vitro stimulation by ' crude 
lymphokines from methoxytryptamine - treated mice 
(N = 20/group).Results are expressed as means + 
standard deviation (n = 3). VEH = control, MEL = 












Macrophages : P8I5 Cells 
Figure 4.18 In vitro killing of murine mastocytoma P815 cells by 
peritoneal macrophages of control mice (N = 20/group) 
after in vitro stimulation by crude lymphokines from , 
melatonin - treated or methoxytryptamine - treated 
mice (N = 20/group). Results are expressed as 'means 
+ standard deviation (n = 3). An asterisk (*) denotes 
a statistically significant difference (p < 0.05) from 
control. A cross (+) denotes a statistically significant 
difference (p < 0.05) from melatonin group. VEH = 
control, MEL = melatonin, MT A = methoxytryptamine. 
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Macrophages : P8I5 Cells 
Figure 4.19 In vitro killing of murine mastocytoma P815 cells by 
peritoneal macrophages from melatonin - treated mice 
(N . = 20/group) after in vitro by crude lymphokines 
from melatonin - treated · or methoxytryp~ine -
treated mice- (N = 20/group). Results are expressed as 
means + standard deviation (n ·= '3). An asterisk (*) 
denotes a statistically significant difference (p < 0.05) 
from control. A cross ( + ) denotes a statistically 
significant difference (p < 0.05) from melatonin group. 
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Macrophages : P815 Cells 
Figure 4.20 In vitro killing of murine mastocytoma P815 cells .by 
peritoneal macrophages from 'methoxytryptamine -
tre~ted mice (N = 20/group) after in vitro stimulation 
by crude lymphokines from melatonin - treated or 
methoxytryptamine - treated mice (N = 20/group). 
Results are expressed as means + standard deviation (n 
= 3). An asterisk (*) denotes a statistically significant 
difference (p < 0.05) from control. A cross (+) 
denotes a statistically significant difference (p < 0.05) 
from .melatonin group. VEH = control, MEL -
melatonin, MTA = methoxytryptamine. 
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Chapter 5 General Discussion 
Clinical trials of melatonin therapy in metastatic patients have been done recently in 
Italy. : Lissoni (l989) treated metastatic cancer patients who did not respond to 
standard therapies, with .intramuscular injections of melatonin (20 mg daily) followed 
by oral administration of melatonin (10 mg daily) · in a maintenance period after 
remission. Eight of the fourteen patients showed· improvement in their performance 
status. The T4{f8 ratio of in patients who did not show progress was significantly 
higher after therapy than before therapy but was still lower than the ratio in patients 
wJ10 showed progress. ·The serum levels of growth hormone, ;somatomectin-C, arid 
B-endorphin were not affected by melatonin administration. Based upon "his finding 
and the fact that the biochemical basis of melatonin therapy ha-s not been 
documented, he suggested that melatonin therapy may be of value- in treating 
untreatable metastatic cancer patients. 
Based on the in vitro results obtained in this project, several hypotheses are made 
with reference to the inhibitory actions of melatonin on human cancers such as the 
example described above. First, methoxytryptamine, one of the derivatives of 
melatonin, we:t;e found to be the most potent among the tested indoles in inhibiting 
inco!poration of 3H-tnymidine in most tumor cell lines. Administration of melatonin 
either orally or intramuscularly could lead to an increase in the plasma level of 
melatonin, which could in turn increase the plasma level of methoxytryptamine. The 
inhibitory action of melatonin in cancer may be a result of an elevation of 
methoxytryptamine level. However, limited availability of assays to measure the 
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serum levels of methoxytryptamine and other pineal indoles In patients after 
melatonin therapy hinders further investigation. 
Second, the mitogenic responses of splenocytes to Con A, which is a T cell mitogen, 
and LPS, which is a B cell mitogen, were found to be the highest in mice receiving 
melatonin in the drinking water. Splenocytes from the melatonin - treated group 
produced higher levels of y-interferon and interleukin-2 than splenocytes from the 
methoxytryptamine - treated group which in turn produced higher levels of y-
interferon and interleukin-2 than splenocytes from the contro1.group. y-Interferon is 
one of the macrophage activating factors. Interleukin-2, known as T cell-growth 
factor, is required for cytotoxic T cell growth. Crude lymphokines from splenocytes 
of the melatonin '- treated group were able to stimulate macrophages of all three 
groups to produce the highest level of nitrite which is essential to the tumoricidal 
activity of macrophages. It is consistent with the finding that crude lymphokines 
from splenocytes of the melatonin - treated group were able to stimulate macrophages 
of all three groups to achieve the greatest inhibition of the growth of the murine 
mastocytoma P8I5 cells. Interestingly, crude lymphokines from splenocytes of the 
methoxytryptamine - treated group were able to stimulate higher nitrite production 
when compared to the control group, but lower than the melatonin-treated group by 
macrophages from the melatonin-treated group and the methoxytryptamine-treated 
group but not the control group. However, it did not lead to greater inhibition of the 
growth of murine mastocytoma P8I5 cells when compared to the control group. 
Thus the data suggest that mela~onin is more potent than methoxytryptamine in 
stimulating the lymphocytes. On the whole, melatonin was able to enhance the cell-
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mediated immune response of the host through an activation of lymphocytes, which 
include T lymphocytes and B lymphocytes. · Maestroni (1986) has demonstrated that 
melatonin was able to enhance the antibody response in vivo. Macrophages from 
both melatonin-treated mice and methoxytryptamine-treated mice only responded to 
activation by crude lymphokines from melatonin - treated mice to achieve a 
significantly higher inhibition of the growth of murine mastocytoma P815 cells than 
the control. Methoxytryptamine was less effective than melatonin in enhancing the 
responses of lymphocytes according to the results obtained in the present 
investigation. Elucidation of the detailed mechanisms requires further investigations. 
Thirdly, only macrophage-mediated cytotoxicity, which was also only restricted to 
antibody-independent manner, was studied although effector · cells of cell-mediated 
immunity included other cell types such as cytotoxic T cells, natural killer cells, and 
granulocytes. Macrophages from the melatonin - treated group were found to achieve , 
a higher production of nitrite, superoxide, and tumor necrosis factor-a than the 
control group. Macrophages from the methoxytryptamine - treated group were found 
to achieve a lower production of hydrogen peroxide, 'superoxide but a higher 
production of tumor necrosis factor-a than the control group. These parameters are 
related to the tumoncidal activity of macrophages. When in vitro lymphokine 
activation was not involved, melatonin was found to be more effective than 
methoxytryptamine in enhancing these functions of macrophages. However, 
macrophages from the methoxytryptamine - treated . group demonstrated a higher 
nitrite production than macrophages from the melatonin - treated group or the control 
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group in response to crude lymphokines from anyone of the three groups were used. 
On the whole, methoxytryptamine seemed to be more effective ' in enhancing the 
macrophage functions tested than melatonin. This awaits confIrmation. If verified, 
it would interestingly demonstrate that the pineal indoles (melatonin and . 
methoxytryptamine) have slightly different role to play in the immunomodulatory 
process, that is melatonin stimulates the lymphocytes more . potently while 
methoxytryptamine is more stimulatory to the macrophages. 
All of these results show that pineal indoles have antitumor potential. They express 
it- not only in a direct manner, but. also in an indIrect manner. TI1ey have 
immunoenhancing potential although much more work needs to be done t6 extend the 
present findings. ' 
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